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 H. pylori is a human gastric pathogen responsible for serious health conditions such as 
gastritis and peptic ulcers.  It requires polar sheathed flagella for initial colonization and 
manifestation of infection in the human stomach.  The export of flagellum components requires 
a specialized protein complex called the export apparatus.  FliI ATPase, FliH, and FliJ are major 
soluble components of the flagellar export apparatus.  FliI is thought to provide energy for export 
of flagellum components by converting the energy of ATP hydrolysis into energy for export of 
proteins.  In vitro, FliH is a negative regulator of FliI ATPase activity.  FliJ is a general export 
co-chaperone.  In the case of H. pylori, there is no strong evidence for the existence of FliJ.  There 
are other important proteins involved in flagellum assembly such as flagellin, FliS and FlhA.  The 
project involves protein characterization and crystallization studies of proteins FliH, FliI, FliS, 
flagellin and the identification of FliJ in H. pylori.   
 The in-vitro characterization studies of two constructs of H. pylori FliH (FliH (57-258) 
and FliH (73-258)) suggests that FliH likely forms a homodimer in solution and it forms an 
elongated structure.  The crystallization studies of both these proteins yielded beautiful crystals 
but getting structural information was challenging due to diffraction quality of the crystals.  The 
site-directed mutagenesis of FliI was successfully performed to produce FliIE193Q mutant.  The 
protein characterization studies showed that FliIE193Q mutant precipitates at every stage of 
purification.  The gel filtration suggests that it forms a monomer in solution. The crystallization 
studies of FliIE193Q mutant did not produce any crystals possibly due to solubility issues.  The 
interaction studies of FliH and the FliIE193Q mutant suggests that it most likely forms FliH2:FliI 
complex.  
 Bioinformatics studies suggests HP0256 as a potential homolog of FliJ (Douillard et al., 
2010).  The protein characterization studies showed that HP0256 forms a monomer in solution. 
Unfortunately, no crystals were observed for HP0256.  The structural studies of FliS showed that 
it forms an antiparallel four-helix bundle.  The binding studies (GST-pulldown) of FliS and 
flagellin showed that the flagellin forms a complex with the FliS.   
 Overall, we have characterized some of the key proteins from the H. pylori flagellar 
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1. Introduction  
1.1 Characteristics of the human gastric pathogen, Helicobacter pylori 
 The idea that the human stomach is a sterile organ, was changed with the discovery of 
Helicobacter pylori from gastric biopsies by Warren and Marshall in 1983 (Warren and Marshall, 
1983).  Initially, this bacterium was named as Campylobacter pyloridis but in 1989, after 
comparing the DNA sequence with other data, it was shown that this bacterium does not belong 
to the Campylobacter genus.  It was then placed in its own genus, Helicobacter.  The name 
pylorus means pyloric valve (the valve opening to the duodenum) (Mobley et al., 2001).   
1.1.1 Classification, gene organization and general metabolism in H. pylori 
 The human gastric pathogen, Helicobacter pylori is a Gram-negative member of the class 
Epsilon proteobacteria.  It infects the gastric mucosa of more than 50% of the world’s population 
thus it is the most prevalent of all the bacterial infections.  In developing countries, the prevalence 
can be as high as 80-90%, whereas, in industrialized countries, it is lower, ranging between 10-
50 % (Rothebacher and Brenner, 2003).  It causes chronic inflammation of the inner wall of the 
stomach i.e. gastritis and it is the main cause of peptic ulcers (Blaser, 2006).  H. pylori is also 
associated with stomach cancer and a rare type of cancer called MALT (mucosa-associated 
lymphoid tissue) lymphoma.  In cancer-related deaths worldwide, gastric adenocarcinoma is the 
second leading cause (Ferlay et al., 2010).   
 The International Agency for Research into Cancer (IARC) (a part of the World Health 
Organization - WHO) has classified H. pylori as a “Class I Carcinogen”.  Along with gastric 
diseases, studies also suggest that H. pylori might also be a causative agent of some non-gastric 
diseases such as chronic liver disease and vascular disease (Pellicano et al., 2009).  H. pylori have 
evolved strategies to downregulate the activation of host immune cells and escape immune 
effector cells (Blaser and Antherton, 2004).  H. pylori is motile by means of several polar 
sheathed flagella which provide locomotion.  The flagellum is also necessary for the initial gastric 
colonization of the bacterium (Otemann and Lowenthal, 2002).  The study of the effect of 
virulence on gnotobiotic piglets strongly correlates motility to the virulence of some bacteria like 
C. pylori (Eaton et al., 1989).  Therefore, the basic biology and biochemistry of flagellar protein 
export mechanism in flagella are of value in understanding H. pylori infection and gastric 
colonization.   
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1.1.2 Bacterial motility 
 The unusual motility of H. pylori in the viscous environment of the gastric mucosa is 
hypothesized to be due to the polar flagella and the helical cell shape.  The flagella provide 
propulsive torque as well as a rotary movement while the helical cell shape creates a corkscrew-
like rotation, which allows bacteria to promote motility in the viscous mucus (Berg et al., 1979; 
Ferrero and Lee, 1988).  The helical shape is the resultant of cell elongation, curvature and twist.  
However, study of H. pylori mutants with less helical cell bodies showed that it retains the 
capacity of high swimming velocity in viscous liquids, suggesting that helical shape may not be 
a critical factor for motility (Bonis et al., 2010; Sycuro et al., 2010).  Flagellar motility is a very 
important determinant for colonization by H. pylori, presumably allowing migration towards the 
gastric mucus as well as allowing movement within the mucus to reach microenvironments 
favorable to growth.  Helicobacter species demonstrate a high locomotion rate in viscous 
environments compared with many motile bacteria.  Salmonella and E. coli (peritrichous, rod 
shaped bacteria) swim with highest velocities in low to slightly viscous substances but their 
velocity decreases with increase in the viscosity of the environment (Lertsethtakarn et al., 2011).  
In contrast, H. pylori (polar flagella, helical bacteria) demonstrate approximately twice the 
velocity of rod-shaped bacteria in slightly viscous substance and can retain these velocities even 
in a highly viscous environment (Lertsethtakarn et al., 2011).   
1.1.3 H. pylori motility, colonization of gastric mucosa and virulence   
 Persistent colonization and infection of gastric mucosa by H. pylori is possible due to 
motility, physical environment of the stomach, biochemical factors, virulence factors, as well as 
genomic diversity of the bacterium.  The microenvironment of the gastric lumen and mucosa 
contains a variety of biochemical factors which are hostile to bacteria.  H. pylori can grow in 
liquid environment around pH 5.1, meaning the bacteria can survive with the acidity of stomach 
after being ingested orally with food.  After oral ingestion, H. pylori must survive the acidic 
lumen of the stomach until penetration of the gastric mucus, after which it will have to survive in 
the pH gradient of the gastric mucus layer.  The activity of the enzymes such as urease, 
formamidase and arginase which are associated with production of ammonium ions help the 
bacteria to endure the acidic environment.  For hydrolysis of urea present in the gastric mucus 
layer, H. pylori uses urease enzyme and produces NH3.  This NH3 rapidly diffuses to the mucus 
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layer and increases the pH, thus allowing penetration into the mucus layer by coupling the 
corkscrew like propulsive rotation originating from the helical shape and flagellar motility.   
 Mutant H. pylori lacking functional flagella showed loss of mouse infectivity 
demonstrating that functional flagella are required to colonize the host’s stomach (Schoenhofen 
et al., 2006).  The study of the effect of virulence on gnotobiotic piglets strongly correlates 
motility to the virulence of H. pylori (Eaton et al., 1989).  Adherence of H. pylori to the gastric 
mucosa through bacterial envelope structures like adhesins also plays a critical role in initial 
colonization.  Diversification including intragenomic and intergenomic changes of the H. pylori 
genome is likely one of the mechanisms for immunological evasion and adaptation to the gastric 
environment (Rhee et al., 2014).  Two major pathological proteins viz. CagA (cytotoxin-
associated gene A) and VacA (vacuolating cytotoxin A) are determining factors in pathogenesis 
due to H. pylori.  VacA binds to gastric epithelial cells and is internalized, causing cellular 
vacuolation characterized by the accumulation of large vesicles which have the characteristics of 
both late endosomes and early lysosomes (Yamaoka, 2010; Palframan et al., 2012).  CagA when 
injected into the cytosol of the host gastric epithelial cells, triggers signal transduction (e.g. 
proliferation and inflammation), leading ultimately to gastric disease (Yamaoka et al., 2010; Lai 
et al., 2006).  In conclusion, a number of host and bacterial factors are responsible for colonization 
and persistence of H. pylori in the human stomach ultimately resulting in pathogenesis and 
clinical symptoms.   
1.2 The Type III Flagellum Export System  
1.2.1 Type III secretion systems  
 Many bacteria have evolved specialized nanomachines that have the capacity to modulate 
a variety of cellular activities and are used to deliver effector proteins into eukaryotic host cells 
(Alvarez et al., 2009; Galàn, 2009; Llosa et al., 2009) (Figure 1.1).  Macromolecular 
nanomachines help the bacteria to perform complex biological tasks like locomotion and protein 
translocation.  One such nanomachine present in the Gram-negative bacteria is type III secretion 
system (T3SS).  It is a specialized protein-export apparatus that helps bacteria to transport 
proteins across the cell membrane and extracellular spaces.  T3SSs are the best characterized 
amongst the protein injection machines (Buṫṫner, 2012; Cornelis, 2006; Galàn and Wolf-Watz, 
2006).  T3SSs are widespread in nature and play vital roles not only for transport of effector 
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proteins but also in symbiotic interactions with plant, vertebrate or insect hosts (Buṫṫner and He, 
2009; Correa et al., 2012; Silver et al., 2007).  Although this secretion machine is highly 
conserved across most Gram negative bacterial species, the effector proteins that are delivered 
by these nanomachines are specific for each pathogen that encodes them (Galàn, 2009).   
 The T3SS can be broadly classified into two classes: the flagellar T3SS which promote 
cell motility (Erhardt et al., 2010) and the non-flagellar T3SS (NF-T3SS) that promote bacterial 
pathogenesis by injecting effector proteins directly into eukaryotic host cells (Abby and Rocha, 
2012; Buṫṫner, 2012; Erhardt et al., 2010).  We will discuss both types of T3SS in the following 
sections.  The core of the T3SS is the needle complex which is composed of a multi-ring base 
substructure and a needle-shaped extension (Chatterjee et al., 2013; Kosarewicz et al., 2012; 
Loquet et al., 2012; Marlovits et al., 2006; Marlovits et al., 2004; Radics et al., 2014; Worral et 
al., 2011).  The base is approximately 25 X 30 nm and is composed of two inner membrane rings 
(IR1 and IR2) connected to two outer membrane rings (OR1 and OR2) through the neck (Figure 
1.2) (Galàn et al., 2014).   
Figure 1.1. Cartoon representation of an injectisome T3SS.   
The T3SS showing the needle complex delivering the effector proteins into the host cell.  Figure 
adapted from Chatterjee et al., 2013. 
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The lower rings are composed of two proteins (YscJ/PrgK/MxiJ and YscD/PrgH/MxiG in 
Yersinia, Salmonella and Shigella spp., respectively) (Table 1.1), whereas the outer ring and neck 
are composed of just one protein (YscC/ InvG /MxiD) (Galàn et al., 2014).  
 The needle is approximately 50 nm long and it is connected to the base through the inner 
rod.  The inner rod docks into a socket-like structure within the base.  The complete structure is 
traversed by a channel which is approximately 20 Å in diameter that transports proteins (Radics 
et al., 2014).  The needle is assembled from approximately 100 copies of a single subunit, 
PrgI/YscF/MxiH (80 subunits) which are arranged in a helical fashion (Cordes et al., 2003; 
Galkin et al., 2010; Kubori et al., 2000; Loquet et al., 2012)   The tip complex is presumably 
involved in the sensing of the target cells as well as in the distribution of the protein translocases 
(Epier et al., 2012; Mueller et al., 2005).  The proximal end is connected to an export apparatus 
(EA) as well as to an ATPase complex in the cytosol.  The export apparatus consists of a group 
of proteins located at the center of the inner rings that serves as a channel for mediating the 
passage of type III secreted proteins through the inner membrane (Wagner et al., 2010).   
 All T3SSs show the presence of five highly conserved inner membrane proteins (Table 
1.1) (InvA, SpaP, SpaQ, SpaR, and SpaS in Salmonella spp.) (flagellum counter parts- FlhA, 
FliP, FliQ, FliR, FlhB respectively) which are essential for the function of T3SS (Allaoui et al., 
1994; Fields et al., 1994; Galàn et al., 1992; Ginocchio and Galàn, 1995; Groisman and Ochman, 
1993; Plano et al., 1991).  Finally, many cytoplasmic proteins are attached to the cytoplasmic 
side of the needle complex and are essential for secretion.  Many of these proteins are well 
conserved among all T3SSs (Collazo et al., 1996; Collazo et al., 1995; Eichelberg et al., 1994; 
Fields et al., 1994; Morita et al., 2006; Woestyn et al., 1994).  As recently suggested by electron 
tomographic studies of the needle complex in situ, these proteins are presumed to be forming a 
defined structure, (Abrusci et al., 2013; Kawamoto et al., 2013; Kudryashev et al., 2013).  An 
ATPase complex is another highly conserved cytosolic component.  Finally, the passage of 
effector proteins into eukaryotic cells is mediated by the protein translocases (SipB/SipC, in 
Salmonella) (Collazo and Galán, 1997; Rosqvist et al., 1995).  Although so much information is 
available about the structure of the T3SS, there are some protein densities observed in the high-
resolution cryo-EM map that are still not accounted for (Galàn et al., 2014).  
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 Some of the protein densities are most likely to represent transmembrane domains of 
components of the export apparatus, whose crystal structures are not yet available.  Remarkable 
progress in the last ten years made it possible to unravel part of the mystery of the structure and 
organization of the type III secretion machine.  Finally, the importance of the T3SS in bacterial 
pathogenesis has stimulated efforts to design/develop novel therapeutic strategies.  It is 
speculated that during the next few years these efforts will begin to translate into effective 
therapeutics.   
Figure 1.2. General schematic diagram and cryo-EM image of the Salmonella T3SS.   
A. The cartoon representation of a typical T3SS showing major substructure (the export 
apparatus (EA), the needle/hook, the tip and the ATPase complex) localization with respect to 
the outer membrane (OM), inner membrane (IM) and peptidoglycan layer (PG).  B.  Surface 
image of the 3-D reconstruction of the cryo–electron microscopy (cryo-EM) map of the needle 
complex from S. typhimurium showing different substructures.  Figure adapted from (Galàn et 





Table 1.1. Nomenclature of specific T3SS secretion components from commonly studied 
bacteria.   
A previously suggested Sct nomenclature system is given for reference.  The table is adapted 




spp.   
Shigella 





Proposed function  
SctF YscF MxiH  PrgI - Needle filament component 
SctI YscI MxiI PrgJ - Inner rod protein 
SctC YscC MxiD InvG - Needle complex outer rings  
SctD YscD MxiG  PrgH - Needle complex inner rings 
SctJ YscJ MxiJ  PrgK FliF Needle complex inner rings 
SctR YscR Spa24  SpaP FliP Export apparatus  
SctS YscS Spa9  SpaQ FliQ Export apparatus  
SctT YscT Spa29  SpaR FliR Export apparatus  
SctU YscU Spa40  SpaS FlhB Export apparatus; substrate 
switching 
SctV YscV MxiA  InvA FlhA Export apparatus  
SctK YscK MxiK  OrgA FliG  Cytoplasmic sorting 
platform 






SctL YscL MxiN  OrgB FliH Links ATPase to sorting 
platform  
SctN YscN Spa47  InvC FliI ATPase 
SctO YscO Spa13  InvI FliJ Flagellum specific 
Chaperone  




1.2.2 Structure of the bacterial flagellum and its T3SS 
 The majority of the swimming bacteria use a reversible, self-assembling, rotary motor 
called the flagellum (Figure 1.3).  Bacteria can actively move using this nanomachine.  There are 
a number of different proposed models for assembly, structure and function of this rotary motor 
(Soutourina and Bertin, 2003; Pallen and Matzke, 2006).  In enteric bacteria flagellar assembly 
is a very tightly regulated process (Chevance and Hughes, 2008; Macnab, 2003; Aldridge and 
Hughes, 2002; Chilcott and Hughes, 2000).  
 
 
Figure 1.3.  Schematic diagram of the flagellum.   
A. The flagellum consists of the basal body, the hook, the hook-filament junction zone, the 
filament and the filament cap.  Most flagellar component proteins are transported using a specific 
export apparatus from the cytoplasm to the distal end of the growing flagellar structure where 
their assembly occurs.  OM, outer membrane; PG, peptidoglycan layer; CM, cytoplasmic 
membrane (Figure from Minamino, 2014).  B. Components of the flagellum and flagellar export 





 E. coli and Salmonella (in Gram-negative bacteria) and Bacillus (Gram-positive) are the 
major model organisms that have provided detailed insights into understanding the structure, 
assembly, and function of the bacterial flagellum (Minamino and Imada, 2015).  Flagella respond 
to external stimuli by a mechanism called chemotaxis.  (Bourret and Stock, 2002; Bren and 
Eisenbach, 2000).  The flagellum is mainly divided into three parts: the basal body rod, the hook 
and the filament (Figure 1.3).  The basal body contains the flagellar motor and also includes a 
rotor, a stator, a rod and a bushing complex surrounding the distal rod.  The flagellar motor 
contains approximately 40 different types of proteins.  The motor generates torque from ion flux 
across the inner membrane thus facilitating flagellum rotation (Chen et al., 2011).  The rotor is 
present in the inner cell membrane, and it is attached to the flagellar filament via the hook 
(universal joint).  The filament is made up of about 20,000 copies of the flagellin proteins which 
are exported to the tip of the filament through the central channel passing through an annular pore 
located in the basal body (Fan et al., 1997).  These flagellins collectively form a helical structure 
with a hollow core, approximately 15 nm in diameter and 15µm in length (Berg et al., 2002).  
The scaffold present at the tip is made up of five copies of the hook-associated proteins that help 
in folding and polymerization of flagellin subunits (Merz et al., 2000).   
 The flagellar basal body consists of the MS ring, rod, and L- and P- rings.  An outer ring 
known as the L-ring (lipopolysaccharide) is present only in gram-negative bacteria.  The P ring 
is present in the peptidoglycan layer.  Due to the absence of an outer membrane, motile Gram 
positive bacteria do not possess the outer pair of rings.  The flagellar basal body consists of a 
specialized protein export apparatus that is required for assembly of the flagellum.  It is a highly 
dynamic structure coordinating protein export.  The export apparatus is composed of a 
transmembrane export gate (made up of FlhA, FlhB, FliO, FliP, FliQ, FliR) and a cytoplasmic 
ATPase complex composed of FliH, FliI and FliJ (Minamino et al., 2008a; Minamino, 2014).  
We will discuss the detailed structure of the export apparatus in the next section.   
 The flagellar rotary motor is powered by a proton gradient across the cytoplasmic 
membrane (Meister et al., 1987; Manson et al., 1977).  Certain alkalophilic organisms, as well as 
some bacteria like Bacillus, utilize a Na+ driven motor (Imae and Atsumi, 1989).  Export of 
flagellum proteins requires both ATP and the membrane Proton Motive Force (PMF) (Macnab, 
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1996; Paul et al., 2008).  For flagellar secretion and rotation, PMF is required whereas ATP 
hydrolysis might be limited to substrate delivery.   
1.2.3 Flagellar T3SSs 
 The secretion of extracellular components of the flagellum is carried out by their own 
specialized T3SS.  Flagellar export in Salmonella, E. coli, B. subtilis, H. pylori and other bacteria 
uses a specialized T3SS present at the base of the flagellum.  There are sequence and structural 
similarities between bacterial flagella, T3SS and their subunits demonstrating that the flagellum 
T3SS and the Gram negative pathogenic T3SSs very likely derived from a common ancestor 
(Blocker et al., 2003).   
 Secretion of flagellar proteins requires at least 11 components of the export apparatus 
(Figure 1.4).  Out of 11 components, 7 are membrane proteins (FlhA, FlhB, FliF, FliO, FliP, FliQ 
and FliR) that are present in the flagellar basal body (Fan et al., 1997; Minamino and 
Macnab,1999).  Three other proteins (FliI, FliH and FliJ) are soluble cytoplasmic components, 
forming the ATPase complex.  FliI ATPase is thought to provide energy for export by converting 
energy of ATP hydrolysis into energy for export of proteins (Fan et al., 1997).  FliH is a negative 
regulator of FliI; and FliJ is a general flagellar secretion co-chaperone (Minamino and Macnab, 
2000b).  Remarkably, FliH shows sequence similarity to the b & δ subunits of FOF1 ATPase, 
while FliI shows significant sequence similarity to the catalytic β- subunit of FOF1 ATPase 
(Albertini et al., 1991; Vogler et al., 1991; Lane et al., 2006), including some well-conserved 
residues present in the Walker box motifs (Minamino and Macnab, 2000b; Imada et al., 2007).  
In the case of H. pylori and other Epsilon proteobacteria there is little evidence of the presence 
of FliJ.  However, CJJ81176_1489 from Campylobacter jejuni showed low but significant 
sequence similarity to FliJ hence, it was proposed that CJJ81176_1489 is a homolog of FliJ (Gao 
et al., 2014).  Deletion of this gene in Campylobacter jejuni resulted in complete absence of 
flagella suggesting that this gene is essential for flagellar assembly.  A recent bioinformatics and 
motility analysis have identified HP0256 as a potential FliJ homologue (Douillard et al., 2010) 
and is required for full motility.   
There are number of differences between Salmonella and H. pylori flagellar export 
systems.  In H. pylori the flagellar genes are under the control of independent promoters.  The 
genetic organization of 40 genes which are required for flagellar assembly and/or function is 
 11 
 
completely different in H. pylori as compared to other bacteria.  Many flagellar genes appeared 
to be scattered in H. pylori as opposed to the well-defined (clustered) organization in Salmonella, 
E. coli etc.  Furthermore H. pylori, has a number of atypical features in the flagellar genetics 
which makes H. pylori a unique system.  We will discuss H. pylori specific flagellar system in 
section 1.3.   
 
 
Figure 1.4. Cartoon representation of a comparative model of the flagellar type III export 
apparatus and FOF1 ATP synthase.   
Transmembrane domain of the export apparatus is composed of FlhA, FlhB, FliO, FliP, FliQ and 
FliR that are located within MS ring.  FliI6-FliJ ring complex shows remarkable similarity to the 
α3β3γ ring complex of FOF1-ATPsynthase.  FlhA anf FlhB forms the export gate.  FliH anchors the 
FliI6-FliJ ring complex to the export gate.  FliH is homologous to b and δ subunits of peripheral 






1.2.4 Flagellum and injectisome T3SS: Morphological similarities and shared genes  
 The evolutionary relation between the flagellum and the Type III injectisome has been 
always a subject of debate.  Early phylogenetic studies suggested that both these systems share a 
common ancestor while recent studies indicate that modern injectisomes are derived from non-
flagellar ancestors (Diepold and Armitrage, 2015). The flagellum and the injectisome are 
debatabely the most fascinating and complex nanomachines found in bacteria.  While the term 
‘T3SS’ is sometimes used to represent the whole injectisome, in this study it will be used to 
represent the export machinery present in both, ‘the flagellum’ as well as ‘the injectisome’.   
 Similar to the injectisome, the flagellar basal body (FBB) is made up of a multi-ring 
structure that spans both the bacterial membranes and the peptidoglycan (Minamino and Namba, 
2008) (Figure 1.5).  A part of the T3SS machinery, the injectisome resembles Hook-Basal body 
(HBB) complex of the flagellum (Kubori et al., 1998; Thomas et al., 2001).  The bacterial 
injectisome and flagellum both consists of large assemblies of 20-30 different proteins.  These 
proteins are exported to the distal ends in both nanomachines with the help of a specialized, 
conserved protein export machinery classified as T3SS.  Their basal bodies house the T3SS 
export apparatus (Hueck, 1998; Minamino and Namba, 2008).  Injectisome and FBB isolated 
from bacterial cells share a highly similar architecture as viewed by electron microscopy (Kubori 
et al., 1998; Schraidt et al., 2011; Thomas et al., 2006).  Also, many of their component proteins 
are homologous (Hueck, 1998; Kosarewicz et al., 2012) which strongly suggests that 
injectisomes are evolutionally related to the flagella.  Both T3SS shows the presence of a 
membrane-embedded export gate and a cytoplasmic protein complex with an ATPase.   
 Table 1.1 shows the common proteins present in both the systems.  In the injectisome, 
five membrane proteins make up the export gate.  The proteins SctR, SctS, SctT, SctU and SctV, 
form the export gate in the injectisome while the export gate of the Salmonella flagellar protein 
export apparatus is made up of six membrane proteins, namely, FlhA, FlhB, FliO, FliP, FliQ, 
FliR.  The InvC ATPase (homolog of SctN ATPase) forms a homo-hexameric ring on the 
cytoplasmic side with OrgA, OrgB and InvI (homologs-SctK, SctL, SctO respectively) 
(Kawamoto et al., 2013; Hu et al., 2015).  The FliI from flagellum export apparatus forms a 
hexamer ring complex with FliH and FliJ (Minamino et al., 2008a).  In injectisome, the export 
gate components are present in the central part of the inner membrane ring (IR) complexes 
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(Wagner et al., 2010).  SctQ forms a sorting platform by providing specific binding sites for SctK 
and SctL.  SctN ATPase is important for chaperone release and substrate unfolding.  The C-ring 
(composed of FliG, FliM and FliN) is clearly visible in the flagellum system as a part of the 
switch complex.  In case of injectisome, though there are homologous proteins, no C-ring 
structure was detected (Kawamoto et al., 2013; Kudryashev et al., 2013).  Recent genetic studies 
and evolutionary analysis have suggested that injectisome evolved from the flagellum (Abby and 
Rocha, 2012) and then adapted to different eukaryotic cells but the core structure was conserved 
throughout the process.   
 
 
Figure 1.5. Structural model of the flagellar as well as injectisome T3SS.   
Structural components listed in the center are present in both T3SS.  Flagellum specific 
components are listed on the left side whereas injectisome specific components are listed on the 




1.2.5 Common evolutionary relation between rotary ATPases and the flagellar export 
apparatus 
 F-V family ATPases/ATP synthases couple ATP hydrolysis or synthesis to ion/proton 
translocation across the cellular membranes.  Rotary ATPases are found across all life forms and 
the overall architecture in all of them is similar.  On functional properties and taxonomic origin, 
three evolutionarily subtypes of Rotary ATPase are evidenet as F, V and A type (Cross and 
Muller, 2004) (Figure 1.6).   
 Prokaryotes predominantly have either F-ATPases (FOF1) which synthesizes ATP or V-
ATPases (VOV1), which functions to pump protons across the membrane.  Eukaryotes have both 
F-ATPases and V-ATPases, which can function either to pump protons in or outside the 
membrane, depending on the assigned function (Nakano et al., 2008 and Feniouk et al., 2007).  
F-type ATP synthases are present in mitochondria or chloroplasts where they function as 
biological power converters (Iino and Noji, 2013).  Eukaryotic V-ATPases are driven by ATP 
hydrolysis and mainly acidify organelles such as endosomes, lysosomes, Golgi-derived vesicles 
and the vacuoles (Forgac, 2007; Li and Kane 2009).  As compared to prokaryotes, eukaryotes 
work oppositely by hydrolyzing ATP and using the energy to drive protons across the membrane 
(Jefferies et al., 2008).  A-type ATPase complexes are very common in well-known 
archaebacteria, which are evolutionarily closer to V-ATPases and mainly hydrolyze ATP (Cross 









                                       
Figure 1.6. Schematic diagrams of rotary ATPase, Flagellar export system and their major 
subunits.   
A. Bacterial F-type ATPases/synthases showing membrane embedded Fo motor, soluble F1 
motor (is made up of α3β3γ subunits), and one peripheral stalk (made up of b and δ subunits).  
These ATPases can synthesize ATP as well as act as proton pumps when ATP levels are high.  
B. Bacterial V-type & archaeal A-type ATPases share a common architecture.  The minimal 
rotary domain is comprised of A3B3D subunits.  They contain two peripheral stalks and are 
believed to be bifunctional.  Subunits that bind to nucleotide are shown in grey color, remaining 
stator subunits in blue, rotary subunits in red color and protons indicated as white spheres (Figure 
from Stewart et al., 2014). C. The flagellar type III export system consists of an export gate 
made (FlhA, FlhB, FliO, FliP, FliQ and FliR) and a water-soluble ATPase complex (FliH, FliI, 
and FliJ).  The FliI6-FliJ structure from cryo-EM studies shows striking structural similarity to 
F1/V1 subunits.  FliH also shows sequence similarity to peripheral stalk subunit E of V-ATPase 
(Figure from Büttner, 2012). 
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 All types of rotary ATPases have two motors, one of them contains a nucleotide binding 
site for ATP whereas the other is a membrane bound motor for translocating protons/ions 
(Stewart et al., 2014).  In F-type ATPase, the minimal ATP-driven rotor is F1, which is made up 
of α3β3γ subunits.  The γ subunit is comprised of two domains, a coiled-coil domain penetrating 
the central α3β3 cylinder and another one is a globular domain with a α/β fold which is in contact 
with the F1-ε subunit (Kishikawa et al., 2013).  Similarly, in V-type ATPases, the minimal rotary 
domain is comprised of A3B3D subunits.  It has been suggested that due to the presence of long 
α-helices, the D-subunit is most likely to be an analog of F1 γ even though there is no significant 
sequence similarity between them (Mulkidjanian et al., 2007; Kishikawa et al., 2013).  The 
central stalk of all the ATPases is important for rotary catalysis, and therefore the distinct lack of 
conservation in the F - and V ‑ type ATPase stalks may have a connection with their evolutionary 
origin.  It was proposed that ancestors of these enzymes lacked a central stalk.  The major 
difference between all the ATPases exists in the peripheral stalks.  The peripheral stalk connects 
the cytoplasmic ATPase domain (F1/ V1/A1) to the membrane embedded domain (FO/ VO/AO).  
F-ATP-synthases contains one peripheral stalk (subunits- b and δ) (Dunn et al., 2000; Dickson et 
al., 2006) (Figure 1.6) while A-ATPases contain two peripheral stalks (subunits E and G) (Lee et 
al., 2010).  Eukaryotic V-ATPases contains three peripheral stalks (Kitagawa et al., 2008).  Each 
peripheral stalk is made up of a heterodimer of E and G subunits.  Out of the three stalks, two 
connect the ATPase domain to membrane bound domain while third stalk is attached to C-subunit 
(absent in F-ATP synthases/A-ATPases) (Oot et al., 2012).   
 The FliI ATPase from the flagellar export apparatus shows extensive sequence and 
structural similarity to the F1- α/β and V1-A/B subunits (Imada et al., 2007).  FliJ shows a striking 
structural similarity to the F1-γ subunit (Ibuki et al., 2013).  The coiled-coil domain of FliJ is also 
present in the non-flagellar Type-III homolog YscO-like proteins (Lorenzini et al., 2010).  FliJ 
promotes FliI6 ring formation by binding to the center of the hexameric ring thus facilitating FliI 
ATPase activity (Minamino et al., 2008b).  Similar arrangement is found in the FOF1-ATPase 
where the antiparallel α helical coiled-coil of the γ subunit penetrates into the center of the α3β3 
ring.  Kishikawa et al., have proposed that FliJ, V1-D, and F1- γ all are evolved from a common 
evolutionary origin (Kishikawa et al., 2013). 
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Figure 1.7. Proposed evolutionary relation between F‑ and V‑type ATPases and flagellar 
T3SS.  
Ancestral, hypothetical semi-permeable membranes are shown by empty circles whereas 
modern, ion-tight membranes are shown in brown circles and dense curved lines.  The proposed 
hypothesis regarding two peripheral stalks in the primordial protein translocase as well as in the 
T3SSs is based on the assumption that only one peripheral stalk (in the absence of the 
translocated substrate) would make the translocase unstable.  The central panel shows the 
common ancestors of F- and V-type ATPases which are the three consecutive evolutionary 
intermediates.  The translocated, partially unfolded protein is denoted by the purple tubes.  The 
translocated protein that is trapped in the membrane translocase channel is shown in red colored 
tube.  (Figure was adapted from Mulkidjanian et al., 2007) 
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 Based on all the above facts it was suggested that the type III export system share 
similarity with rotary ATPases and share a common evolutionary origin with the bacterial 
flagellar and non-flagellar type III export system (Figure 1.7) (Mulkidjanian et al., 2007).  They 
have proposed that the origin of the rotary cation-translocating ATPases started with an RNA 
helicase (Rho transcription terminator) and a membrane channel.  Even though there needs to be 
more evidence in this field, based on all structural and sequence comparison it can be stated that 
rotary ATPases and flagellar export apparatus very likely share a common evolutionary origin.   
1.3 H. pylori specific flagellum proteins  
1.3.1 H. pylori flagellum export apparatus  
 Recent in-situ cryoelectron tomography studies in C. jejuni and H. pylori have shown that 
the flagella of these organisms are among the most diverse flagella since they have unique 
ultrastructural components (Gao et al., 2014).  The understanding of flagellar export apparatus of 
H. pylori is still somehwhat limited as compared to that in E. coli and Salmonella.  There is 
evidence identifying many proteins (FliI, FliH, FliP, FliQ, FlhA, FlhB) that constitute the 
flagellar export locus in H. pylori (Porwollik et al., 1999).  Recently a FliO homolog has been 
identified in H. pylori and it is larger in size as compared to its counterparts in E. coli and 
Salmonella (Tsang and Hoover, 2014).  The H. pylori FliO homolog is predicted to have a large 
N-terminal periplasmic domain (Tsang and Hoover, 2014).  There is very little evidence for the 
presence of FliJ in H. pylori but a potential homolog HP0256 has been identified which shows 
15% sequence identity with B. subtilis FliJ and aligns reasonably well with other FliJ homologs 
(Douillard et al., 2010).  Characterizing the roles of all components of the flagellar export 
apparatus in H. pylori is crucial for understanding how this organism coordinates flagellar gene 
expression with flagellum assembly.  
1.3.2 H. pylori flagellum gene regulation  
 In H. pylori, a complex cellular process such as flagellum formation is coordinately 
regulated despite of the fact that it contains fewer gene regulatory factors than other bacteria (Alm 
et. al., 1999).  Flagellar biosynthesis is a hierarchical process involving sequential activation of 
approximately 40 genes (Niehus et al., 2004; Macnab, 2003).  However, in H. pylori, the master 
regulator of flagellar biosynthesis (FlhCD) has not been found which could link flagellar 
biosynthesis with the cell cycle (Spohn and Scarlatto, 1999; Niehus et al., 2004).  In contrast to 
 19 
 
other bacteria, the flagellar genes of H. pylori are scattered throughout the genome in 25 or more 
transcriptional units (Macnab, 1992).  Flagellar biosynthesis studies in H. pylori have shown that 
regulation of flagellar genes is a complex process and involves three sigma factors (σ28, σ54, 
and σ80).   
 In H. pylori, the primary sigma factor (σ80) is required for the regulation of the expression 
of housekeeping genes (class I genes) along with some other essential genes.  The other genes 
are the genes encoding flagellar export apparatus components, flagellar basal body proteins as 
well as chemotaxis proteins (Beier et al., 1997; Porwollik et al., 1999; Spohn and Scarlatto, 
1999).  σ54 (RpoN) and FlgR (σ54 dependent activator) are required for the expression of the 
genes (class II genes) encoding components of the hook, hook-associated proteins, the rod and 
the minor flagellin FlaB (Spohn and Scarlatto, 1999).  In Salmonella, the hook length is under 
the control of FliK (Ferris and Minamino, 2006).  In H. pylori FliK has been identified as a 
product of gene HP0906 (Ryan et al., 2005).  The novel Zn-finger protein HP0958 interacts with 
the sigma factor RpoN (Rain et al., 2001).  σ54 (RpoN) activity is modulated by completion of 
the hook structure in H. pylori (Douillard et al., 2008).  A HP0958 deletion impairs transcription 
of the major flagellin (FlaA), minor flagellin (FlaB) and genes encoding flagellar components.  
σ28 (FliA) controls the expression of late flagellar genes (class III genes) including the gene 
encoding the major flagellin (flaA) as well as proteins involved in flagellin modification and 
export (flaG and fliS) (Niehus et al., 2004).  It also regulates expression of the gene encoding the 
filament capping protein (fliD) (Kim et al., 1999; Leying et al., 1992; Tomb et al., 1997).  σ28 
activity is tightly regulated by the anti-σ28 factor FlgM (Colland et al., 2001).  FlgM secretion 
relieves this repression in other organism (Kutsukake, 1994) but in case of H. pylori FlgM 
secretion has not been demonstrated (Douillard et al., 2008).   
1.3.3 Flagellum specific export proteins that are not evident in the H. pylori genome 
 Many flagellar export proteins and chaperones have been identified in Salmonella.  
Flagellar chaperones FlgN, FliT and FliS are required for the stability as well as of secretion of 
the substrates FlgK, FlgL, FliC and FliD (Auvray et al., 2001; Fraser et al., 1999; Bennett and 
Hughes, 2000).  With the exception of a few flagellar genes, homologues for all of the export 
apparatus proteins have been found or annotated in H. pylori (Tsang and Hoover, 2014).  The 
flagellar genes that have not been identified in H. pylori include export protein FliO, FliJ, FliT 
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and FlgN.  This may be due to low sequence identity (Tsang and Hoover, 2014; Douillard et al., 
2010).  Sequences of the proteins of flagellar export apparatus (FlhA, FlhB, FliP, FliQ, and FliR) 
and FliN have been found to be highly conserved among the various Helicobacter species.  Out 
of the six flagellar export apparatus proteins, FliO is the least conserved protein.  A potential FliO 
homolog, HP0583, have been characterized in H. pylori recently but it is predicted to have an N-
terminal periplasmic domain which is absent in Salmonella FliO (Tsang and Hoover, 2014).  
Similar to FliO, a potential FliJ homolog (HP0256) have been identified by bioinformatics 
analysis using only the FliJ N-terminal coiled-coil domain as a search query (Douillard et al 
2010).  Although HP0256 has a different function in H. pylori than FliJ in Salmonella, it is 
definitely required for full motility.  We will discuss in detail about HP0256 in section 1.4.3.  FliT 
gene have been found in other bacteria like E. coli, Salmonella, B. subtilis (Chen and Helmann, 
1994; Kawagishi et al., 1992) but in H. pylori fliT gene homologue has not been found (Tomb et 
al., 1997).  Similarly, FlgN has not been reported in H. pylori (Lam et al., 2010).   
1.4 Structures and functions of proteins FliH, FliI, FliJ, FliS and FlaA 
1.4.1 FliH 
 FliH is one of the major soluble component of the flagellar export system and it interacts 
with the cytoplasmic component FliI (Minamino and Macnab, 2000b).  Originally FliH was 
thought to be the regulator of FliI ATPase, since it reduces the ATPase activity of FliI potentially 
preventing futile ATP hydrolysis (Minamino and Macnab, 2000a).  In other words, FliH acts as 
a regulator of FliI to prevent it from wasting ATP when FliI is not engaged in flagellar protein 
export (Minamino and Macnab, 2000b; González-Pedrajo et al., 2002).  However, 
overexpression of FliI ATPase or certain mutations in FlhA or FlhB can bypass the effects of 
FliH null mutants (Minamino et al., 2003).  Interestingly overexpression of FliH in otherwise 
wild-type cells also reduces motility which can be explained by the excessive formation of a 
FliI:FliH2 heterotrimer (Minamino and Macnab, 2000b) thus apparently preventing FliI 
hexamerization and incorporation into the export apparatus.  FliH binds to FliI and anchors the 
FliI hexamer to the export gate (Minamino et al., 2014) thus FliH provides a link between FliI 
hexamer formation and protein export (Minamino et al., 2003; Minamino and Macnab, 2000b; 
Lane et al., 2006).  It is proposed that FliH plays an important role in the effective docking of 
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FliI to the export gate so that the energy of ATP hydrolysis can be usefully coupled to the 
translocation of export substrates (Minamino et al., 2003). 
 In all, both FliI and FliH are required for efficient export, and they must be expressed in 
a proper ratio.  The N-terminal and C-terminal domain sequences of FliH are homologous to 
those of the FOF1-ATP synthase, b and δ subunits, respectively (Pallen et al., 2006; Lane et al., 
2006).  H. pylori FliH consists of 258 amino acid residues while Salmonella FliH is 234 amino 
acid long.  The Salmonella FliH sequence can be divided into three regions: an N-terminal region 
(residues 1–100: FliHN), a central region (residues 101–140: FliHM) and a C-terminal region 
(residues 141–235: FliHC) (González-Pedrajo et al., 2002) (Figure 1.8).  In vitro characterization 
of Salmonella FliH has revealed that it forms an elongated dimer in solution (Minamino et al., 
2002; Lane et al., 2006).  A central region in Salmonella FliH (residues 101 and 140) is required 
for homodimer formation and contains a sequence with a probability of forming a helical coiled-
coil.  Residues 100–235 of Salmonella FliH are required for interaction with FliI.  The N-terminal 
residues of FliH bind to the flagellar chaperone FliJ (Gonzàlez-Pedrajo et al., 2002).  A conserved 
AxxxG(xxxG)mxxxA (where the value of m varies considerably) motif spanning residues 59–94 
in Salmonella FliH suggests that these FliH GxxxG repeats may have a role in the regulation of 
the activity of FliI ATPase (Trost & Moore, 2009; Minamino et al., 2009).  Deletion of residues 
60-100 from Salmonella FliH have been shown to enhance FliI ATPase activity in-vitro 
(Gonzàlez-Pedrajo et al., 2002).  The extreme N-terminal region of FliH interacts with the 
transmembrane domain of FlhA (Noritaka et al., 2012).  Highly conserved residues of Salmonella 
FliH, Trp-7 and Trp-10, are not only important for interaction with FliN but also for docking of 
FliHI complex to the export gate thus it is suggested that the interactions of Trp-7 and Trp-10 
with FliN allow the FliH–FliI complex to be localized to the C ring (Minamino et al., 2009).  This 
interaction also increases local concentration of FliI near the export gate (Noritaka et al., 2012).  
However, it is proposed that these interactions must be highly dynamic because localization of 
FliI or FliH to the C ring is one of the steps on its way to the docking platform (Minamino et al., 
2003; Minamino and Namba, 2008).   
Recently the structure of Salmonella FliHC (residues 99-235) in complex with FliI has 
shown that FliHC forms unusually asymmetric homodimer (Imada et al., 2016).  The two subunits 
(FliHC-A and FliHC-B) forming the FliHC dimer, have a different 3D arrangement in the FliHI 
complex (Figure 1.8 and Figure 1.9).  FliHC-A consists of a N-terminal helix (α1), a central 
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globular domain made up of two α-helices (α2 and α3) and four β-strands (β1-4) and a C-terminal 
helix (α4) (Figure 1.8).  A small bend at residue Leu-119 divides α1 into two parts α1a and α1b.  
FliHC-B consists of five α-helices (α1-4 and αs) and three β-strands (β1-3) (Figure 1.9).  The N-
terminal α1 helix is completely divided into two parts (α1a and α1b) by the kink between the two 
residues, Ile-123 and Ala-124.  The hydrophobic core is exposed due to absence of α2 and β4 
from the globular domain.  The α2 helix turns its orientation while β4 changes its conformation 
to a loop.  α4 adopts two completely different conformations in a dimer (Figure 1.9B).   
 FliHC2 resembles the peripheral stalk subunits (E and G) of A/V type ATPases (Imada et 
al., 2016).  Despite this information, the crystal structure of full length FliH (Salmonella / H. 
pylori) is not yet available.  Crystal structures as well as careful biochemical/biological analysis 
of this protein should ultimately be able to solve the fascinating issues related to FliH structure 




Figure 1.8. Structure of Salmonella FliHC-A (residues 99-235).   
The Cα ribbon drawing of FliHC-A showing N-terminal helix (α1), a central globular domain 
(made up of two α-helices (α2 and α3) and four β-strands (β1-4)) and a C-terminal helix (α4).  
All the helices are shown in cyan and β-strands are in red.  The figure was created using PyMOL 




    
Figure 1.9. Structure of Salmonella FliHC-B (residues 99-235). 
The Cα ribbon drawing of FliHC-B shown in rainbow colors (N-terminus (blue) to C-terminus 
(red)).  FliHC-B shows two different conformations in a dimer A and B.  A. FliHC-B consists of 
five α-helices (α1-4 and αs) and three β-strands (β1-3).  The N-terminal α1 helix is completely 
divided into α1a and α1b.  The hydrophobic core is exposed due to absence of α2 and β4 from 
the globular domain.  The α2 helix turns its orientation while β4 changes its conformation to a 
loop.  B. α4 completely changes its conformation.  (Imada et al., 2016).  Both the figures were 












 The soluble component FliI of the flagellar export system is a Walker type ATPase (Fan 
et al., 1996).  FliI was thought to convert chemical energy from ATP hydrolysis into mechanical 
work which drives the export process since FliI containing mutants show an impaired mechanism 
of flagellar protein export (Fan et al., 1996 and Jenks et al., 1997).  FliI shows extensive similarity 
to the α and β subunits of FOF1 ATP synthase (Imada et al., 2007) but this sequence similarity 
was mostly limited to the ATPase domains (Lane et al., 2006 and Volger et al., 1991).  FliI self 
assembles to form a homohexamer (Auvray et al., 2002; Claret et al., 2003), especially in the 
presence of ATP or FliJ.  The ATPase InvC from T3SS shares a high degree of sequence identity 
with FliI.  InvC has a similar role of substrate recognition and the hexameric form of InvC is 
required for higher efficiency (Roblin et al., 2014).   
 H. pylori FliI is a 47 kDa (434 amino acids) protein.  FliI consists of three domains - the 
N-terminal domain, which interacts with FliH (Minamino et al., 2000, Lane et al., 2006), the 
central domain showing the presence of a catalytic site for ATP hydrolysis, and a helical C-
terminal domain (Imada et al., 2007).  The catalytic site is conserved along with the residues of 
the P-loop (Walker A motif), where phosphates of the ATP binds.  H. pylori FliI shows 26% 
sequence identity with the β-subunit of the bovine F1 - ATPase.  The structure of Salmonella FliI 
shares a striking structural similarity to α and β subunits of F1 - ATPase (Imada et al., 2007).  
Residues of α & β subunits involved in ATP hydrolysis are highly conserved in FliI (Imada et 
al., 2007 & Vogler et al., 1991).   
 An N-terminal double mutant (R7C/L12P) or the mutant lacking first seven residues of 
Salmonella FliI, failed to interact with FliH in vitro (Minamino et al., 2000).  N-terminal 
truncated versions of FliI do not form a complex with FliH hence the FliI N-terminus is thought 
to play an important role in FliH interaction (Minamino et al., 2001; Lane et al., 2006).  The 
sequence of the central ATPase domain shows extensive similarity to the primary sequence of 
the β subunit of F1-ATPase (Vogler et al., 1991) (Figure 1.10).  It was thought that FliI and F1-
ATPase share a similar pathway for ATP hydrolysis since ADP binds to the P-loop (Walker-
loop) of FliI in a similar fashion to that in the F1 ATPase α and β subunits (Imada et al., 2007).   
 Previously it was suggested that Salmonella FliI self-assembles into a homo-hexameric 
ring and exerts its ATPase activity (Claret et al., 2003; Minamino et al., 2006).  In solutions 
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lacking ATP, FliI is largely monomeric while the amount of the FliI hexamer increases with 
increase in the ATP concentration or the concentration of its non-hydrolysable analog, ATPγS or 
AMP-PNP (Adenosine 5’-(β, γ-imido) triphosphate tetra lithium salt hydrate) (Claret et al., 
2003).  From in vitro reconstitution experiments, it was previously observed that the binding of 
Mg2+-ATP or analogs of ATP to FliI induce FliI6 ring formation and that ATP hydrolysis 
followed by release of ADP and Pi destabilizes the ring (Minamino et al., 2009).  Hence it was 
suggested that the assembly-disassembly cycle of the FliI hexameric ring occurs is an ATP 
dependent process.  In agreement with this suggestion, the K188I mutation of Salmonella FliI, 
which reduces the affinity of FliI for ATP, remarkably decreased the efficiency of FliI hexameric 
ring formation (Bai et al., 2014).  On the other hand, the E211Q active site mutation of Salmonella 
FliI, resulting in the complete loss of the ATPase activity, formed FliI rings in the presence of 
Mg2+-ATP (Kazetani et al., 2009).  This suggests that the assemble-disassembly of FliI hexamer 
occurs in ATP-dependent manner.   
 FliI forms a complex with a homo-dimer of FliH (Minamino et al., 2000).  It has been 
proposed that the FliH2FliI complex acts as a dynamic carrier and the FlhA9 ring acts as a sorting 
platform.  FlhA allows fast and efficient entry of export substrates into the export gate with the 
help of the FliI hexameric ring, which appears to act as a static substrate loader (Bai et al., 2014).  
Recently, it has been indicated that the rate of ATP hydrolysis by FliI does not directly determine 
the flagellar protein export and thus the FliI hexameric ring does not facilitate the entry of 
substrates into the export gate (Minamino et al., 2014).   
 Figure 1.11 shows the 2.4 Å resolution structure of Salmonella FliI (Δ1–18) in the 
presence of ADP (Imada et al., 2007).  Removal of the first 18 residues from native FliI made it 
more soluble and easy for crystallization.  The asymmetric unit of the crystal contains two 
molecules of FliI (Δ1–18) and these molecules were related by a pseudo 2-fold symmetry axis.  
The N-terminal domain contains six β strands while the ATPase domain having 272 residues 
shows an α / β fold.  The ATPase domain is composed of 10 α helices and13 β strands.  The 
central part of the ATPase domain has a P loop containing the Walker A and B motif, (Figure 
1.11).  The C-terminal domain has two loops that connect three α helices.  The ATPase domain 
is connected to N-terminal domain through a long linker segment (Asn-98 through Lys-108).   
FliI active site mutation  
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 Glutamate 193 plays an important role in ATP hydrolysis and it is conserved in FliI 
homologs.  The carboxyl group of Glutamate 193 (similar to Glu-190 in the thermophilic Bacillus 
F1 - ATPase), polarizes a water molecule for the nucleophilic attack to the γ-phosphate of ATP 
(a general base catalysis), and hence the replacement of Glutamate by Glutamine should result in 
the complete loss of ATPase activity (Shimabukuro et al., 2003; Kazetani et al., 2009) since the 
carboxyl group will be now replaced by an amide group. 
The E211Q mutation in Salmonella FliI caused a loss-of-function phenotype and it 
significantly reduced the ATPase activity of FliI (Kazetani et al., 2009).  FliI activity increases 
in the presence of ATP/FliJ, probably due to allosteric activation of the enzyme.  Thus we hoped 
that the expression of H. pylori FliI E/Q mutant in the presence of AMP-PNP (a non-hydrolysable 
analog of ATP) will help to reveal whether this substrate binds to the active site of the FliI which 
might create a conformational change thus regaining ATPase activity allosterically.  It is shown 
that the yield of complete hexameric FliI rings increases by 20-fold when AMP-PNP was used 
instead of ATP, presumably by stabilizing the assembled oligomers (Claret et al., 2003), hence 






Figure 1.10. A multiple sequence alignment of the N terminus of FliI, Type III secretion 
ATPases from various bacteria, and α and β subunits of F1-ATPase.   
Secondary structure units are shown for the known structures of the N-terminal domains of F1 
ATPase α and β subunit.  The α-helices are depicted by cylinders and β-strands are depicted by 
arrows.  Residues making up the hydrophobic core in the F1 ATPase subunits are shown in green.  
Highly conserved residues are shown in pink.  H. pylori FliI shows 48% sequence identity with 




Figure 1.11. Structure of Salmonella FliI (Δ1–18).   
A. The structure of FliI (Δ1–18) showing N-term β-sheet in blue color, central α-helical ATPase 
domain in green and C-terminal domain in red.  The missing linker region (from the model) that 
connects the N-terminal and ATPase domain is shown by dashed line.  B. The stereo view of the 
nucleotide-binding site showing ADP is green, the residues interacting with ADP are colored 
cyan.  The conserved residues taking part in catalysis are shown in yellow.  (Imada et al., 2007). 











 Out of the three soluble components of the flagellar export system, the third protein is 
FliJ.  It is a small (147 residue) protein in Salmonella, with a deduced molecular mass of 17 kDa 
(Ibuki et al., 2008).  Salmonella FliJ has a high proportion (31 mol %) of charged residues, and 
a high-helical propensity (Vogler et al., 1991).  Many Type III export chaperones also show these 
characteristics (Bennet and Hughes, 2000).  FliJ is an essential component for protein export in 
Salmonella, as lack of FliJ results in a leaky motile phenotype (Minamino et al., 2000).  It 
interacts with various flagellar axial proteins.  Originally FliJ was postulated to function as a 
general chaperone for the export substrate proteins (Minamino et al., 2000) but a recent structural 
study established that it is homologous to the γ subunit of the FOF1 ATP synthase (Ibuki et al., 
2011) (Figure 1.12) and hence may function as an integral component of the FliH–FliI–FliJ 
ATPase complex.  FliJ binds to other export chaperones like FliT and FlgN (Evans et al., 2006), 
hence may function as a co-chaperone.  
 FliJ interacts not only with the FliH–FliI complex but also with the cytoplasmic domains 
of FlhA and FlhB (export-gate proteins) (Minamino & Macnab, 2000a; Fraser et al., 2003).  FliJ 
modifies the binding abilities of FlhAC (Bange et al., 2010).  It also interacts with FliM and other 
flagellar specific chaperones such as FliT and FlgN (Gonza´lez-Pedrajo et al., 2006, Evans et al., 
2006).  FliJ was shown to have a moonlighting role to cycle export chaperones FlgN (chaperone 
for hook–filament junction proteins FlgK and FlgL) and FliT (chaperone for filament cap protein 
FliD), but not FliS, the chaperone of the major filament protein, FliC (flagellin) (Evans et al., 
2006).  Overexpression of FliJ in otherwise wild-type cells also reduces motility (Minamino et 
al., 2000a).  FliJ stabilizes FliI hexamric ring (Ibuki et al., 2011).  
FliJ is considered to regulate the export process through complex interactions, but the 
detailed function of FliJ is still unknown.  Therefore, the three-dimensional structure of FliJ is 
essential in order to understand the mechanism of flagellar protein export as well as the role of 
FliJ in export process.  In the case of H. pylori there is no strong evidence for the presence of 
FliJ.  Previous bioinformatics, motility and mutagenesis studies have identified HP0256 as a 
potential FliJ homologue (Douillard et al., 2010).  HP0256 from H. pylori shows 38% sequence 
identity with Salmonella FliJ (Figure 1.13).  HP0256 gene encodes a 17 kDa protein having pI of 
7.8.  B. subtilis FliJ is predicted to have α-helical structure with the possibility of forming a C-
terminal coiled-coil (Wolf et al., 1997).   
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The structure of Salmonella FliJ (PDB ID 3AJW) (Ibuki et al., 2011) (Figure 1.12B) showed that 
FliJ forms an antiparallel coiled-coil structure made up of two helices, α1 and α2. Since α1 was 
shorter than α2, the N- and C-terminal short segments of α2 protruded from the core of coiled-
coil.  Due to strong aggregating tendacy of FliJ, it was difficult to crystllize hence a His-tag was 
attached to N-terminus which made it more soluble and easy to crystallize (Ibuki et al., 2011).   
 
 
Figure 1.12. Structural similarity between Salmonella FliJ and γ subunit of F1-ATPAse.   
A. Cα ribbon diagram of the γ subunit of bovine F1-ATPase (PDB ID 1E79).  B. Cα ribbon 
diagram of Salmonella FliJ (PDB ID 3AJW). The binding regions for FliH (red-orange), FliT and 
FliH both (yellow), FliT (green) FlgN (sky-blue) respectively (Ibuki et al., 2011).  Both the 







Figure 1.13. Sequence similarity between FliJ homologs.   
A multiple sequence alignment of the HP0256 and FliJ homologs from other organisms.  The 
conserved residues are indicated in red.  HP0256 shows highest sequence identity with 
Salmonella FliJ (3AJW) and C. Jejuni FliJ whereas lowest sequence identity with C. tetani.  









1.4.4 The FliH:FliI:FliJ complex  
 FliI ATPase forms a hexamer to fully exert its ATPase activity (Claret et al., 2003) and 
FliJ forms the FliI6FliJ complex by binding to the center of FliI hexameric ring (Ibuki et al., 
2011).  FliI also forms a complex with a homo-dimer of FliH (Imada et al., 2007).  The FliH2FliI 
complex is believed to deliver export substrates as well as chaperone-substrate complexes to the 
export gate because chaperone-substrate complexes bind to the FliH2FliI complex through 
cooperative interactions among FliI, chaperone, and substrate (Thomas et al., 2004; Minamino et 
al., 2012).  An interaction of the extreme N-terminal region of FliH with FliN allows the FliH2FliI 
complex to bind to the C ring (Minamino et al., 2009). FliJ interacts with FliI hexameric ring and 
with the FliH2FliI complex (González-Pedrajo et al., 2002).  It is proposed that FliH helps the 
FliJ and the chaperone-export substrate complexes to anchor to its docking platform (FlhA9-
FlhBC) (Bai et al., 2014).  Taken together, FliI and FliH, both are required for delivery of export 
substrates to the export gate (Minamino et al., 2008a) and it is proposed that FliH and FliI helps 
to enforce the interaction between FlhA and its binding proteins to maintain an efficient energy 
coupling mechanism of flagellar protein export (Minamino et al., 2016) 
 Recently, the structure of Salmonella FliHC-FliI heterotrimer has been solved (Imada et 
al., 2016) which showed that FliHC2 forms an unusually asymmetric homodimer that binds to the 
N-terminal domain of FliI (Figure 1.14).  The Structure of FliHC-A and FliHC-B is shown in 
results section 1.4.1.  The globular domain of FliHC-A interacts with the N-terminal α-helix of 
FliI.  This helix fits into the hydrophobic groove made up of α1 helices of both FliHC.  The 
residues from Salmonella FliI that are important for this interaction are Arg-4, Arg-7, Trp-8, Leu-
12, Phe-15 and Met-19.  The hydrophobic grove is formed by residues Ile-123, Leu-127, Met-
128, and Leu-132 (from α1b domain of FliHC-A) and Phe-112, Leu-116, and Leu-119 (from α1a 
domain of FliHC-B), Leu-127, Met-130, and Ala-134 (from α1a domain of FliHC-B).   
 In this crystal structure, the interaction of FliHC with the oligomerization interface of FliI 
is not observed hence it is still not clear how FliH regulates the FliI hexamerization.  In A/V type 
ATPases the conformational change of peripheral stalk subunit is required for assembly of the 
complex (Bernal and Stock, 2004) thus it might be possible that the change in conformation of 





Figure 1.14. The structure of Salmonella FliHC2–FliI.  
Cα ribbon representation of the FliHC2–FliI complex showing FliI (green) and two FliHC 
subunits (FliHC-A and FliHC-B in cyan, and magenta, respectively).  The ADP molecule is 
shown in red.  The figure was created using PyMOL using the structure of FliHC2–FliI complex 









 Studies of the flagellar export system have shown that FliS acts as the flagellin-specific 
chaperone that binds to flagellin to prevent premature polymerization of newly synthesized 
flagellin molecules (Auvray et al., 2001; Ozin et al., 2003; Muskotàl et al., 2006).  From the 
genetic analyses in various bacteria like E. coli (Kawagishi et al., 1992), Bacillus (Chen and 
Helmann, 1994), and Salmonella (Yokoseki et al., 1995), it was confirmed that the fliS gene is 
necessary for flagellation.  FliS also acts as a negative regulator for the export of the flagellum-
specific anti- sigma factor, FlgM, in Salmonella (Yokoseki et al., 1996) but it is not yet clear 
whether it plays the same role in other microbes.  In H. pylori, mutation in FliS results in non-
motile and non-flagellate bacteria (Allan et al., 2000) due to reduced levels of both flagellin as 
well as the flagellar hook subunit FlgE suggesting that FliS might be involved in export of hook 
component proteins.   
   
 
Figure 1.15. Cartoon representation of structure of FliS from H. pylori.   
The structure of H. pylori FliS (PDB ID 3IQC) showing the presence of a core 4-helix bundle. 




In addition to the flagellin subunits (FlaA and FlaB), FliS has shown to interact with a number of 
other proteins (Lam et al., 2010).  H. pylori FliS consists of 126 amino acid residues and it shares 
37% sequence identity with Salmonella FliS.  The crystal structure of FliS from Aquifex aeolicus 
showed that it has a 4-helix bundle structure.  This 4-helix bundle interacts with the C-terminal 
disordered region of flagellin which is neccessary for oligomerization.  The structure of H. pylori 
FliS solved at 2.7 Å showed that FliS consists of a 4-helix bundle (Lam et al., 2010) (PDB ID 
3IQC) (Figure 1.15).  The flagellin binding pocket is present near the N-terminal end and this 
pocket is blocked by conserved residues Tyr10, Tyr28 and, Tyr 84.  Residues of the surface loop 
between helices showed low sequence identity with FliS from A. aeolicus.  Tyr10 occupied 
position in the hydrophobic pocket similar to FliS from A. aeolicus suggesting that FliS-flagellin 
must be conserved in other organisms like H. pylori.  It also suggests that N-terminal fragment is 
important for blocking of flagellin binding.  The exact mechanism of action of FliS in H. pylori 
remains to be elucidated.   
1.4.6 Flagellin 
 A major flagellin subunit, FlaA (53 kDa) and a minor flagellin subunit FlaB (54 kDa) are 
the two structural subunits of H. pylori flagellar filament (Josenhans and Suerbaum, 2002; Leying 
et al., 1992).  The genes encoding both these flagellins are located at different sites on the H. 
pylori chromosome and are transcriptionally regulated by distinct promoters (Josenhans and 
Suerbaum, 2002).  σ factors play an important role in controlling transcription of multiple 
flagellin genes (Chevance and Hughes, 2008).  σ 70, σ 28, and σ 54 are mostly involved in 
recognition of flagellar gene promoters.  In most of the bacteria containing multiple-flagellins, 
the major flagellins are under the control of σ 28, such as in Helicobacter pylori, Salmonella etc. 
(reviewed in Sun et al., 2014).  Both of these flagellins play essential role in persistent 
colonization of the bacterium (Eaton et al., 1996).  However, one of the flagellins (FlaA) 
constitutes the major part of the flagellar filament.   
1.4.7 FliS:Flagellin complex 
 The B. subtilis FliS-flagellin complex binds to the cytoplasmic domain of FlhA (one of 
the export gate component) (Bange et al., 2010).  The structure of H. pylori FlhA has been already 
solved in Dr. Moore’s lab (Moore and Jia, 2010).  We hypothesized that in H. pylori, the 
FliS:Flagellin complex should interact with FlhA.  Therefore, in order to study the interaction of 
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FliS-flagellin with FlhA, we first decided to understand FliS-flagellin interaction in H. pylori.  
Structural studies in A. aeolicus have demonstrated that FliS forms a complex with flagellin in 
1:1 stoichiometry (PDB ID 1ORY).  In A. aeolicus, the C-terminal residues 479-518 of flagellin 
(FliC) were found to wrap around the surface of FliS in a horseshoe-like confirmation (Figure 
1.16A).  The hydrophobic interactions are predominantly present on the interface between the 
two molecules.   The binding of FliS by flagellin is accompanied by the conformational 
changes in the FliS molecule.  The N-terminus of FliS is disordered and it forms a quasi-helical 
cap.  This cap is loosely bound and upon binding of flagellin it gets rearranged to form a short 
helix on the side of FliS helix bundle.  This new conformation of FliS has a groove for binding 
of one of the α-helical segments (residues 510–518) of FliC.  At the same time, the helical cap of 
FliS is replaced by the adjacent helical (residues 499–505) segment of FliC.  The residues 
Ala504–Gln505 of FliC occupy equivalent positions as the residues Ala7–Tyr8 of FliS before 
binding (Figure 1.16).   
Figure 1.16. The structure of A. aeolicus FliS-FliC complex.   
A. The structure of A. aeolicus FliS (green) (1002-1121) in complex with FliC (464-518) 
(orange).  The C-terminal end residues of FliC interact with FliS and are wrapped around the 
structure of FliS showing horseshoe like confirmation.  Figure was created using PyMOL (PDB 
ID 1ORY).  B. The intramolecular interactions in the hydrophobic pocket of FliS showing Tyr8.  
Tyr8 of FliS and Gln505 of FliC occupy same position in the hydrophobic pocket of FliS.  
Hydrogen bonds are shown as dashed lines.  Figure adapted from Evdokimov et al., 2003. 
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Therefore, the FliS appears to use the ‘stopper’ mechanism wherein the N terminus of FliS acts 
as a ‘molecular stopper’ to close the hydrophobic binding site whenever FliS is not bound to FliC.  
The high degree of conservation among the residues of FliS that form the binding pocket for 
Gln505 of FliC suggests that Gln505 is a key factor for binding.  The high density of 
intermolecular contacts in this region also suggest that Gln505 is important determinant of the 



























1.5 Project hypothesis and objectives  
Hypothesis 
I. The structure of a FliH C-domain fragment will explain how FliH dimerizes and will 
reveal the tertiary structure of the FliH C-domain globular fragment (residues 171-258).  
Finally, the structure of the FliH C-domain will provide the framework for understanding 
how FliH binds to FliI.  A FliI active site mutation should inactive the ATPase activity 
which should reveal the link between FliI hexamer assembly and disassembly cycle.  This 
will help understand the mechanism of export.  
II. Structural and biochemical information of HP0256 will help to identify HP0256 as a 
homolog of FliJ in H. pylori.  
III. The H. pylori FliS interacts with flagellin.  This interaction study will help to understand 
about how FliS:FliC interact with FlhA. 
 
Objectives 
I. Cloning, purification and crystallization of FliH and FliI for determination of the 
structural basis for FliH dimerization as well as its interaction with FliI ATPase. 
II. Cloning, purification and crystallization of HP0256 to confirm the presence of FliJ in H. 
pylori by determining the structural details of HP0256.   
III. Protein characterization and crystallization studies of FliS to elucidate the structure of 









2. Materials and Methods 
2.1 Primers used for cloning of H. pylori FliH (full length), FliH (57-258), FliH (73-258), 
FliI E193Q mutant, HP0256, FliS, FlaA1 (411-510) & FlaA2 (465-510) 
Table 2.1. List of the PCR primers used in this study for cloning of full length H. pylori 
NCTC 11637 FliH (full length), FliH (57-258), FliH (73-258), FliI E193Q mutant, HP0256, 
FliS, FlaA1 (411-510) & FlaA2 (465-510).   
Each 5’ primer contains a BamHI site and each 3’ primer contains an EcoRI site for directional 
cloning into the pGEX-6P-3 GST fusion protein expression vector.  The restriction sites as well 
as the mutagenic triplet codons with desired single amino acid substitution is shown in boldface 
italic. 
Name of primer 
 
Sequence  
ML076 (Forward primer 
for FliH 2-258) 
5’- GACCTGGGATCCTCATTGAATTAGCCGTAAGAACTT GATTC 
– 3’ 
ML021 (Reverse primer 
for all genes) 
5’-GGTTTGAATTCTCACACCTTAAAATTTTCCAACAC – 3’ 
ML095 (Forward primer 
for FliH 73-258) 
5’- GACCTGGGATCCAGCCATTTAGTGAAATTGCAAATGCAG – 
3’ 
ML096 (Forward primer 
for FliH 57-258) 
5’- GACCTGGGATCCGAAACGATTTGATTGATTGCTTTGTTG – 3’ 
ML097 (Forward primer 
for FliIE193Q mutant) 
5’-GTGATCGCTTTGATTGGGCAGAGGGGCAGAGAAATCCCT-3’ 
ML098 (Reverse primer 
for FliIE193Q mutant) 
5’-AGGGATTTCTCTGCCCCTCTGCCCAATCAAAGCGATCAC-3’ 
ML099 (Forward primer 
for FlaA1 (411-510)) 
5’-GACCTGGGATCCGGATCTGGGGTT ACAACCTTG-3’ 
ML100 (Forward primer 
for FlaA2 (465-510)) 
5’-GACCTGGGATCCGCTGAGTCTAA ATCAGGGATGTG G-3’ 
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ML101 (Reverse primer 
for FlaA1 and FlaA2) 
5’-
GACGAGGAATTCCTAAGTTAAAAGCCTTAAGATATTTTGTTG-3’  
ML102 (Forward primer 
for FliS) 
5’-GACCTGGGATCCATGCAATACGCTAACGCTTATC-3’ 
ML103 (Reverse primer 
for FliS) 
5’-GACGAGGAATTCTTAGGCGAGTTCATCTGAATGGATTTC-3’ 
ML104 (Forward primer 
for HP0256) 
5’-GACCTGGGATCCAAAAAATTCGCTTCTGTGTTGGTG-3’ 




2.2 Cloning procedures 
2.2.1 DNA amplification by PCR 
 The standard cloning protocol for the cloning of gene fragments by Polymerase Chain 
Reaction (PCR) is as follows.  PCR was carried out in a MyCyclerTM Thermal Cycler (Bio-Rad) 
in a total reaction volume of 100 μL.  Each reaction contained 1 ng/μL of template DNA, 1X 
reaction mixture (Fermentas) (10X Pfu buffer + MgSO4), 0.5 mM of dNTP, 200 nM of forward 
and reverse primers, 1 μL of (5000 unit) Pfu DNA polymerase (Fermentas).  A typical 
amplification program (Figure 2.1) consists of total 30-35 cycles.  Each cycle consisted of 1 min 
incubation at 95°C for denaturation of DNA, a 45 sec annealing step at 55°C and 2 min elongation 
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step at 72°C.  In the first cycle, the denaturation step was extended up to 2 min.  In the last cycle, 
the elongation step was extended to 10 min before final hold at 4°C.  
 
Figure 2.1. The temperature profile of a typical PCR reaction cycle.   
The PCR reaction consists of three major steps for amplification of target DNA.  In the first cycle 
of the PCR, denaturation was extended to 2min.  Second step of reaction consists of 30 cycles.  
It consists of denaturation of target DNA at 95°C for 2 mins, annealing of primers to the desired 
target site at 55°C for 45 secs, synthesis of new DNA strand at 72°C for 2 min.  In final step, 









2.2.2 Overview of pGEX-6P-3 vector  
 Glutathione S-transferase (GST) is a naturally occurring 26 KDa protein which has high 
affinity for glutathione coupled to a Sepharose matrix (Harper and Speicher, 2011).  This is a 
reversible binding and the protein can be eluted under mild, non-denaturing conditions using 
reduced glutathione in the elution buffer.  pGEX-6P-3 expression vector (GE healthcare Life 
Science) enables the easy cloning of a variety of protein constructs, transformation of E. coli, and 
selection of transformants by the appropriate antibiotic (ampicillin) (Figure 2.2).  A specific 
PreScission-protease site engineered between the GST moiety and the protein of interest allows 
removal of the GST from the target recombinant protein.  This protease is specific for the core 
amino acid sequence Leu-Phe-Gln/Gly-Pro and it cleaves between the Gln and the Gly residue, 
which has been engineered into the pGEX-6P-3 multiple cloning site (MCS).  PreScission 
Protease is a fusion protein which is genetically engineered and consists of human rhinovirus 
3C protease and GST.  The GST tag permits purification of the recombinant protein by means of 
Glutathione Sepharose (GS) affinity chromatography.  The GST can be easily removed from the 
sample by re-chromatography on a GS column.  
2.2.3 Agarose gel electrophoresis  
 The PCR products were observed for their size by performing Agarose Gel 
electrophoresis.  For preparing a 1% Agarose gel, 0.5 g of Agarose was heated with 50 ml of 1X 
TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA pH 8.3) to dissolve the agarose.  3 
μL of Hydragreen dye (20,000X) (ACTgene) was added after the gel mixture was slightly cooled 
and then poured it into the gel casting tray containing a 10-well comb.  The agarose gel was 
allowed to set for about 25 min and then comb was removed.  The gel was placed in an 
electrophoresis apparatus and submerged into 1x TAE buffer.  8 μL of the PCR product was 
mixed with 2 μL of the 6X loading dye (10 mM Tris-HCl (pH 7.6) 0.03% bromophenol blue, 
0.03% xylene cyanol FF, 60% glycerol 60 mM EDTA) (Fermentas) and loaded into the well.  10 
μL of 1 kb DNA ladder (Fermentas) was also loaded to compare the size of the bands. The gel 
was run at 100V for 45-50 minutes.  The DNA was visualized under gel imager at 365 nm 






Figure 2.2 . Overview of pGEX-6P-3 expression system.   
A. pGEX-6P-3 (4.9 Kbp) vector showing the Multiple Cloning Site (shown in blue color), the 
GST gene (shown in red color), the Amp resistance gene (shown in pink color), origin of 
replication (Ori-shown in yellow color) gene and the endonuclease restriction sites.  (The figure 
was generated using SnapGene software). B. Sequence of the multiple cloning site from pGEX-
6P-3 vector showing PreScission Protease Cleavage Site and cleavage sites for different 





2.2.4 Ethanol precipitation of PCR product  
 As a next step to preserve the PCR products from exonuclease activity, ethanol 
precipitation of PCR products was carried out.  10 % v/v 3M sodium acetate was mixed with the 
PCR reaction mixture, followed by 3X the reaction volume of 95 % ethanol.  The sample was 
mixed thoroughly and kept in -20°C for 15-20 min.  The supernatant was removed carefully after 
centrifugation 16438 x g at 4°C for 5 minutes.  2x 70 % ethanol was added into the reaction 
mixture followed by centrifugation at same conditions for 5 minutes.  Sodium acetate decreases 
the pH of the solution to help in precipitation of DNA.  Ethanol acts as precipitating agent for 
DNA, since it is less polar than water and hence it interferes with the DNA-water interaction thus 
making DNA to precipitate from solution.  The pellet was dried using CentriVap Centrifugal 
Vacuum Concentrator (Labconco) for 15 minutes and then the sample was stored at -20°C.  The 
pellet was dissolved in 20 μL of H2O before restriction digestion. 
2.2.5 Restriction digestion and gel extraction of DNA  
 The product DNA was digested at 37°C O/N with the restriction enzymes BamHI and 
EcoRI (2 μL @20,000 U/mL each), 10 μL of 10X Tango buffer (Fermentas).  The same procedure 
was used to digest the pGEX-6P-3 vector.  The digestion of PCR product is required to cut the 
DNA at appropriate size for amplification of gene of interest.  Again ethanol precipitation of the 
reaction mixture was carried out and the sample was dried by the vacuum concentrator for 15 
min.  The DNA pellet was re-dissolved in 10 μL of ddH2O.  Both the DNA fragments (insert & 
vector) were further purified by Qiagen Gel Extraction kit.  For gel purification, the DNA was 
loaded on 1 % Agarose gel containing 3 μL of Hydragreen dye.  After the DNA extraction step 
the concentration of the insert and plasmid was calculated by measuring absorbance at 260 nm 
using Nanodrop Spectrophotometer (Thermo Scientific Nanodrop 2000c). 
2.2.6 Preparation of competent cells  
 Competent E. coli XL-1 and BL-21 DE3 (BL-21) E. coli cells were prepared from the 
stock culture of respective cells using the following procedure.  Cells were first streked onto 
Luria-Bertani (LB) agar plates without any antibiotic and incubated for 14 - 16 hours at 37°C.  
On the following day, 5 mL LB broth without antibiotic was inoculated with a single colony and 
incubated in orbital shaking incubator for 14 - 16 hours at 37°C and 300 rpm.  Following 
incubation, the culture was diluted in a 1:100 proportion with fresh LB broth.  The diluted culture 
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was grown at 37°C and 300 rpm to an optical density (OD 600 nm) of 0.4 to 0.6 and then cells 
were kept on ice for 5 min.  Cells were harvested by centrifugation in a Beckman-Coulter 
Centrifuge at 2,218 x g and 4 °C for 5 minutes. Supernatant was removed and the cell pellet was 
gently resuspended into ice cold 0.1 M MgCl2 in a 1:5 v/v ratio.  The cell suspension was 
incubated on ice for 1 hour.  Cells were harvested by centrifugation for 5 minutes at 2,218 x g, 
4°C.  The cell pellet was resuspended in 2 mL of 0.1 M CaCl2 plus 14 % glycerol and incubated 
on ice for 1 hour. The aliquots were made in eppendorf tubes and flash frozen with liquid N2 and 
stored at - 80°C.   
2.2.7 DNA Ligation and transformation in E. coli host cells  
 The ligation of the insert DNA into the plasmid was carried out in a molar ratio of 3:1 
(Insert: Vector).  150 ng/μL of insert DNA was mixed with 50 ng/μL of vector (pGEX-6P-3) 
along with 1 μL of the enzyme T4 DNA Ligase (Fermentas) and 1 μL of 10X T4 buffer 
(Fermentas).  Cloning of the gene of interest in multiple cloning site of pGEX-6P-3, expresses 
the protein as GST-fusion protein thus allowing to purify the protein by GST affinity purification 
method.  Transformation was done using E. coli XL-1 host cells since they have the highest 
transformation efficiency.  150 μL E. coli XL-1 cells were incubated with 5 μL of ligation 
reaction for 45 minutes on ice and was spread onto pre-warmed LB agar plate containing Amp 
(final concentration 100 μg/ml).  Mock transformation of double digest plasmid was also carried 
out to check if there is re-ligation of plasmid.  The plates were then incubated at 37°C O/N.  
2.2.8 Recombinant screening  
 To check for the presence of the insert into the colonies, screening of the insert was 
performed using PCR.  Aliquots of 25 μL of the PCR master mix (10X Thermopol buffer, Taq 
polymerase, 5mM dNTPs, 25 μL of forward (GEX-3) & reverse primer @ 20 μM concentration, 
150 μL of dH2O).  25 μL of PCR master mix was inoculated with each colony from the 
transformation.  The standard PCR step was run as per cloning step.  Analysis of the PCR reaction 
was carried out using agarose gel electrophoresis.  5 μL of the sample was run on 1% agarose gel 
containing 3 μL of the Hydra Green dye.  Bands corresponding to insert and plasmid were 
observed under UV light at 365nm wavelength.  
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2.2.9 Plasmid preparation and purification   
 For positive colonies, 5 mL of LB media containing 5 μL of 100 mg/mL Ampicillin stock 
was inoculated and grown overnight at 37°C.  Plasmid purification was carried out using QiaGen 
Plasmid Purification kit, which helps in eluting plasmid DNA.  The concentration of plasmid was 
measured on Nanodrop (A260).  10 μL (100 ng/µL) of purified plasmid was digested using 
restriction enzymes as mentioned in section 2.2.5 and analyzed by Agarose gel electrophoresis.   
2.2.10 DNA sequencing 
 The plasmid samples (200 ng) were sent to PBI-NRC at the U of S, Saskatoon, for DNA 
sequencing to get the sequence of the insert DNA.  All the sequence results were compared with 
genomic DNA (H. pylori NCTC 11637) sequence using nucleotide BLAST to check the identity.  
2.3 Bacterial Strains and growth conditions 
 E. coli strains (Table 2.2) were grown in Luria Bertani (LB) agar plates and LB broth at 
37°C incubation.  For making 1 L of LB broth, 10 g of BactoTM Tryptone (Becton, Dickinson and 
Company, BD), 5 g of BactoTM Yeast Extract (BD) and 10 g of NaCl was dissolved in 1 L of 
deionized water.  For making LB agar, 15 g of DifcoTM Agar was added to 1L LB broth.  The 
broth and LB agar was autoclaved for 20 min at 121°C for sterilization.  LB agar was slightly 
cooled after sterilization and then poured into petri dishes.  
 For growing E. coli cells containing the FliI E193Q mutant plasmid, Hyper BrothTM 
(Athena Enzyme SystemsTM) and Glucose Nutrient Mix (Athena Enzyme SystemsTM) were used.  
150 g of Glucose Nutrient Mix was dissolved in 700 mL deionized water and this solution was 
then filtered using a 0.2 µm filter.  Glucose Nutrient Mix was stored at 4°C.  To make 1 L of 
Hyper Broth, 44.5 g of Hyper broth was dissolved in 1L deionized water and autoclaved at 121°C 
for 15 min.  50 mL of Glucose Nutrient Mix was added to the broth once it is cooled to 







Table 2.2. Bacterial Strains used in this project  
Bacterial strain  Source  
H. pylori CCUG 17874 - H. pylori motile 
strain (H. pylori NCTC 11637) 
Culture collection University of Gothenberg, 
Sweden 
E. coli XL-1 Stratagene® 
E. coli BL-21(DE3)  
 
Novagen®  
2.4 Recombinant Protein methods   
2.4.1 Protein expression trials  
Optimization of protein expression was carried out to find the ideal conditions to get maximum 
expression of recombinant proteins.  To get expression of protein, 40 ng/μL of the plasmid was 
transformed into E. coli BL21 host cells.  1 μL of 40 ng/ μL of plasmid containing the gene of 
interest was added into 100 μL of competent BL21 cells and kept on ice for 30-40 minutes for 
transformation.  Plating was done on LB agar plates with ampicillin and incubated overnight @ 
37°C.  Next day 5 mL of LB media with Amp (100 μg/ml) was inoculated with a single colony 
and incubated O/N at 37°C in Innova 4330 Refrigerated Incubator shaker (New Brunswick 
Scientific).  Next day, 3X 50 mL of LB (50 μL Amp) was inoculated with 500 μL of starter 
culture and incubated @37°C until first one reach an OD of 0.4; second reach an OD of 0.6 and 
third reach an OD600 of 0.8.  Once the desired absorbance was obtained, 0.1 mM of IPTG 
(Isopropyl thiogalactosidase) for protein expression and incubated for three hours @ 37°C.  The 
cells were pelleted and kept in -20°C.  
The same procedure was repeated for expression at 25°C.  After addition of IPTG, flasks were 
incubated at 25°C O/N.  Next day, cells were pelleted and kept at -20°C O/N. 
Four different samples were prepared for SDS-PAGE analysis. 
1. Sample 1(Lysate): - Pellet resuspended in 500 μL 1X PBS buffer and sonicated until 
moderately clarified.  5 μL of this is removed for SDS PAGE analysis. 




3. Sample 3 (Pellet): - The pellet was resuspended in 500 μL of PBS and 5 μL was used for SDS- 
PAGE analysis. 
4. Sample 4 (GST-pull down): - 20 μL of 70% GST-sepharose slurry was added to remaining 
supernatant sample and mixed for 10-20 minutes at room temperature and supernatant was 
removed by centrifugation. The beads were washed with 200 μL of PBS and resuspended in 20 
μL of SDS PAGE loading buffer. 
5. 5 μL of loading buffer was added to samples 1, 2 and 3 and boiled for 2 min. 
6. The SDS PAGE was run of the samples along with molecular mass markers on 15% SDS gel. 
2.4.2 Expression of GST fusion proteins and harvesting cells 
 For transformation of a competent cell line with a desired plasmid, 40 ng/μL of the 
plasmid was transformed into E. coli BL21 host cells & incubated on ice for 30-40 minutes before 
plating on LB agar plate containing ampicillin.  The plate was incubated at 37°C overnight.  Next 
day 50 mL of LB (with 100 μg/ml amp) was inoculated with a single colony from plate and 
incubated for 37°C overnight in a shaker incubator at 200 rpm.  The following day, 2 liters of LB 
(amp) was inoculated with 2 mL of starter culture and incubated at 37°C till the cells reach an 
OD600 of 0.8.  For induction of protein expression, IPTG was added to a final concentration of 
0.1 mM (2 mL) and incubated 25°C overnight in a shaker incubator at 200 rpm.  
 For cell recovery from liquid culture, the cells were spun in a J2-HS centrifuge using the 
JLA 16.250 rotor at 5393 x g for 30 min at 4°C.  The first step in the cell lysis procedure was 
resuspension of the pelleted cells in ice cold lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM 
NaCl, 1 mM EDTA) in a ratio of 1:3 w/v of the pellet to the lysis buffer.  The resuspended cells 
were kept at -20°C until the next step.  
2.4.3 Lysis of cells  
 The falcon tubes containing the cell suspension was kept on ice for 5 min and then allowed 
it to thaw at room temperature.  Once the cells completely thaw, 1 mg/mL of Hen egg white 
lysozyme (Bioshop) was added and incubated on ice for 20 min.  The cells were lysed @ 35 psi 
using a cell disruptor (Constant cell disruptor system) and centrifuged at 20,400 x g in a J2-HS 
centrifuge using a JA-20 rotor for 60 minute at 4°C.  The supernatant was passed through glass 
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wool and further steps of purification by FPLC (Fast performance liquid chromatography) was 
performed. 
2.4.4 Affinity purification of GST-fusion protein  
 For affinity purification of GST-fusion protein, an ӒKTA FPLC and HR 16/5 column 
(Amersham Biosciences) were used.  HR 16/5 column is packed with 25mL of Glutathoine 
SepharoseTM 4B beads (Amersham Phramacia Biotech).  The column was washed with 2 column 
volumes of autoclaved H2O to remove ethanol and then equilibrated with 2 column volumes of 
1X PBS (Phosphate buffered saline, 140 mM of NaCl, 2.7 mM of KCl, 10 mM of Na2HPO4, 1.8 
mM of KH2PO4, pH 7.3).  The lysate supernatant was passed through glass wool to remove 
particulate impurities and then it was applied to the column using a 50 mL SuperloopTM 
(Amersham Pharmacia Biotech) at a flow rate of 1 mL/min.  The column was washed with 3 
column volume of 1X PBS.  The GST fusion protein binds to the column.  It was eluted using 
elution buffer (50 mM Tris HCl pH 8.0, 10 mM reduced glutathione).  Proper fractions 
corresponding to peak of interest were collected and 10 μL of samples were removed for SDS-
PAGE analysis.  
2.4.5 Buffer exchange by dialysis 
 Buffer exchange by selective diffusion plays an important role in protein purification and 
helps in removing small, unwanted molecules from the protein.  Buffer exchange by dialysis was 
achieved by using BioDesign Dialysis TubingTM with a 3,500 molecular weight cut-off (MWCO).  
The dialysis tube was cut to a required length and soaked in water for 15 min.  One end of the 
tube was tied and sealed with a clip.  The protein sample was poured in the tube and other side 
was also knotted.  The sample was subjected to dialysis at 4°C with 4 liter of cleavage buffer (pH 
8.0) (50 mM Tris, 150 mM NaCl, 1 mM EDTA) for 16 hours.  The buffer was changed for another 
five hours. 
2.4.6 Preparation of PreScission protease  
 PreScission Protease (PSP) (46.4 kDa) is a genetically engineered fusion protein of 
glutathione S-transferase (GST) and human rhinovirus (HRV) type 14 3C protease (Walker et al, 
1994).  This protease specifically identifies a subset of sequences having a stretch of amino acids, 
Leu-Phe-Gln/Gly-Pro and cleaves between the Gln and Gly residues (Cordingley et al, 1990).  
After cleavage of GST, it can be easily removed by using Glutathione Sepharose™ 4B.  
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Expression and purification of GST-PSP was done using the same method as explained in section 
2.5.  The lysis buffer (Buffer P) used for GST-PSP purification was prepared by dissolving 50 
mM Tris-HCl, 150 mM NaCl and 10 mM EDTA.  This buffer was autoclaved and 10 mM β-ME 
(β-mercapto-ethanol) was added just before resuspending cells.  
 Resuspended cell solution was kept at -20°C for 24 hours and then lysis and purification 
was carried out using Glutathione sepharose 4BTM column as explained in section 2.4.4.  For 
purification of GST-PSP, 1X buffer P was used instead of 1X PBS.  After running 12% SDS gel, 
appropriate GST-PSP fractions were collected and dialyzed against 4 liter of cold buffer P for 24 
hours.  Fractions with pure GST-PSP were pooled and then concentrated till 15 mg/mL using an 
Amicon® Ultra-15 millipore filter 10,000 MWCO.  The concentration of GST-PSP was 
determined by Nanodrop (A280).  25 % glycerol stock of the protein was prepared in small aliquots 
and kept in -80°C after freezing them in liquid N2.  
2.4.7 GST cleavage using PreScission protease and removal of GST tag 
 The protein solution was transferred to a falcon tube after dialysis.  The GST tag was 
removed using PreScission protease.  The protein was mixed with 80 units of PreScission 
protease to cleave the GST tag and 4 mM DTT was also added.  DTT reduces the disulfide bonds 
of proteins and thus helps to prevent cysteine residues from forming intramolecular and 
intermolecular disulfide bonds.  The protein solution was kept at 4°C for a minimum of 16 hours.  
The GST cleaved protein was then subjected to a 2nd round of GST purification wherein free GST 
binds to the Glutathione SepharoseTM 4B beads and pure protein comes out in flow through 
fractions.   
2.4.8 Ion exchange chromatography  
 Ion exchange chromatography is an effective method used for protein purification.  In 
anion exchange chromatography, negatively charged protein moieties are attracted to a positively 
charged solid support and then increasing gradient of salt is applied to elute the desired protein.  
The flow through fractions from 2nd step of GS affinity purification were collected, pooled and 
subjected to dialysis in buffer A (50 mM Tris pH 8.0, 25 mM NaCl) for ion-exchange 
chromatography.  The protein was purified using an anion exchange column (SourceTM 15 Q 
column) packed in a HR 16/5 column.  The column was pre-equilibrated with 50 mL of buffer 
A.  The protein sample was injected in the column using a superloop at 1 mL/min flow rate.  The 
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protein was eluted with a linear gradient of 25-500 mM NaCl over three column volume using 
elution buffer B (50 mM Tris-HCl pH 8.0, 2 M NaCl) and appropriate fractions containing protein 
of interest were collected.   
2.4.9 Concentration of recombinant proteins  
 The concentration of protein was determined from A280 (absorbance at 280 nm) by 
Nanodrop Spectrophotometer (Thermo Scientific Nanodrop 2000c).  A280 was based on 
extinction coefficient of Tyr and Trp residues present in the protein (1490, 5500 respectively).  
The extinction coefficient of all the proteins was determined by ExPASy ProtParam tool and then 
the concentration was determined by dividing the absorbance by the extinction coefficient.  The 
protein was centrifuged using an Amicon® Ultra-15 centrifugal filter device, 3 kDa Molecular 
Weight Cut Off (MWCO) to a final concentration of 10 mg/mL.  20 mM Bis-Tris propane pH 
7.0, 100 mM NaCl, 2 mM TCEP was used as a buffer.  Buffer exchange helps in removing 
contaminating charged ions in protein solution.  The buffer pH affects the solubility of a protein.  
Finally, the concentration of protein was measured and different concentrations of proteins were 
run on 15% SDS gel to determine the purity.   
2.4.10 Size exclusion chromatography (SEC) 
 Gel filtration or size exclusion chromatography separates molecules/ proteins based on 
their molecular size.  SEC was performed on a SuperdexTM 75 or a SuperdexTM 200 column 
depending on molecular size of proteins.  The two columns differ in the average pore size of the 
matrix hence help in better separation of proteins depending on the molecular size of proteins.  
SuperdexTM 75 column is generally used for proteins with an approximate size between 70 kDa 
and 2 kDa.  SuperdexTM 200 column is generally used for proteins with an approximate size 
between 400 kDa and 7 kDa.  The column was washed with ddH2O and then equilibrated with 20 
mM Tris pH 8.0 and 100 mM NaCl.  The protein was injected to the column using either a 500 
μL or a 2 mL sample loop (GE Life Science).  The flow rate used for sample injection and elution 
was 0.5 mL/min.  The max pressure for both the columns is 1 MPa.  After elution, the column 
was cleaned by 3 CV of H2O and 3 CV of 20 % ethanol, and stored at room temperature.  Based 
on elution volume, molecular mass of the protein was calculated using a standard calibration 
curve.   
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2.4.11 Site Directed Mutagenesis  
 Mutagenesis of FliI was performed using QuikChange® Site-Directed Mutagenesis Kit 
(Agilent technologies).  
Mutant strand synthesis reaction (Thermal Cycling): - A series of sample reactions were set 
up by mixing 10ng, 20ng and 50ng of the plasmid DNA with 5 μL of 10X reaction mixture (100 
mM KCl, 100 mM 100 mM(NH4)2SO4, 200 mM Tris-HCl (pH 8.8), 20 mM MgSO4, 1% Triton® 
X-100, 1 mg/ml nuclease-free BSA).  1.25 μL of each primer (125 ng) (Primers ML097 and 
ML098; See Table 2.2 for primers) was added along with 1 μL of dNTP mix.  Finally, 1 μL of 
PfuTurboTM DNA polymerase was added (2.5 U/ μL).  Thermal cycling of the PCR was carried 
out in a Bio-Rad MyCycler.  The cycling parameters for the mutagenesis are listed in Table 2.3. 
Table 2.3. Cycling parameters for the mutagenic DNA strand synthesis by QuikChange® 
Site-Directed Mutagenesis Kit. 
Segment  
 
Number of cycles  Temperature  Time  
1  
 




16  95°C  
 
30 seconds  
55°C  
 
1 minute  
68°C 
 
5 minute  
 
Following thermal cycling, the reaction was placed on ice for 2 minutes to cool the reaction 
around 37°C. 
DpnI digestion of the amplification products: - The products were digested with 1 μL of DpnI 
(10 U/µL stock) enzyme for 1 hour at 37°C which digests the methylated, non-mutated parental 
plasmid. 
Transformation of XL1-Blue Supercompetent cells - 1 μL of the DpnI treated DNA was added 
to previously thawed 50 μL XL-1 Supercompetent cells (Agilent technologies) and incubated on 
ice for 30 minutes.  The reaction was heated at 42°C for 45 seconds then placed on ice for 2 
minutes.  The reaction was incubated at 37°C for 1hour in a shaker incubator at 200 rpm after 
addition of 0.5 mL of NZY+ broth.  For preparing NZY+ broth, 2 g of NZ amine (Casein 
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hydrolysate) (Sigma-Aldrich), 1 g yeast, 1 g NaCl was dissolved in 200 mL of deionized water 
and autoclaved for 20 min at 121°C.  2.5 mL of 1M MgCl2, 2.5 mL of 1M MgSO4 and 4 mL of 
20% glucose was added to above media prior to use.  
 The 250 μL of reaction volume was plated on LB plate supplemented with 100 mg/mL of 
ampicillin.  The plates were incubated at 37°C for 16 hours.  The following day, 5 mL of LB 
media with ampicillin was inoculated with single colony and incubated at 37°C for 16 hours.  
Plasmid preparation was carried out as mentioned previously in section 2.3.9 and the 
concentration of mutagenic plasmid was determined by Nanodrop (A280 = (0.1 %) = 0.987).  10 
μL of the plasmid was digested to check the size of the inserted gene.  The mutagenized plasmid 
(200 ng) was sent for sequencing PBI-NRC at U of S as mentioned in section 2.3.10.  
2.5 Protein Analysis  
2.5.1 SDS-PAGE 
 For separation and visualization of proteins, Sodium-dodecyl sulfate Polyacrylamide gel 
electrophoresis (SDS-PAGE) using Laemmli method was performed (Laemmli, 1970).  All SDS-
PAGE gels were cast with 15% or 12% resolving gel and 4 % stacking gel by using Hoefer SE245 
Mighty Small Dual Gel Caster (GE Life Science).  For making 15 % resolving gel, 1.85 mL 40 
% acrylamide, 1.38 mL 1.5 M Tris-HCl [pH 8.8 at 25°C], 50 μL 10 % (v/v) SDS, 25 μL 10 % 
APS, 5 μL TEMED were mixed and volume was made up to 5 mL with H2O.  For making 4 % 
stacking gel, (0.25 mL 40 % acrylamide, 0.62 mL 0.5 M Tris-HCl [pH 6.8 at 25°C], 25 μL 10 % 
(w/v) SDS, 25 μL 10 % APS, 5 μL TEMED were mixed and volume was made up to 2.5 mL 
with H2O).  A 12% resolving gel was made by adjusting the amount of 40 % acrylamide and H2O. 
 5 μL of samples were mixed with 5 μL of sample loading buffer (0.5 M Tris-HCl [pH 
6.8], 10 % glycerol, 10 % SDS, 5 % (w/v) β mercaptoethanol, 1 % (w/v) Bromophenol blue).  
The sample was then boiled for 2 min, and 10 μL was loaded on the gel. SDS-PAGE was run at 
a 115 V until the dye front reaches the bottom of the gel (approximately 45 minutes). 
 The running buffer for SDS gel consisted of 1X SDS buffer (25 mM Tris-HCl (pH 8.2), 
200 mM glycine, 0.1 % (w/v) SDS) diluted from a 10X stock solution.  The SDS gel staining 
buffer consisted of Coomassie staining solution (40 % ethanol, 10 % v/v glacial acetic acid, 0.1 
% w/v Coomassie Brilliant Blue).  The gel was stained with Coomassie staining buffer for 30 
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min by gently mixing on an IKA® VIBRAX VXR Basic Orbital Shaker.  Destaining solution 
was prepared by mixing 7.5 % v/v glacial acetic acid, and 10 % v/v ethanol.  The gel was kept 
for destaining in destaining solution for 4-5 hours at room temperature.  Photographic images of 
the SDS-gel were taken using Gel Imager (Syngene Gel Imager). 
2.5.2 Determination of protein concentration  
 A280 of proteins was determined using Nanodrop spectrophotometer (Thermo Scientific 
Nanodrop 2000c).  The spectrophotometer was blanked using 2 μL ddH2O and then A280 of 2 μL 
of protein was determined.  The concentration of protein was then calculated using theoretical 
absorbance of 1 g/L of protein at 280 nm (obtained from ProtParam).  
2.5.3 Protein – protein interaction studies-GST-pull-down assay 
 GST pull-down assay is an in vitro technique used to check protein-protein interaction 
(Brymora et al, 2004).  GST pulldown experiment consists of a GST-fusion protein (the bait) 
mixed with an excess of the recombinant tag-free protein (the prey).  The bait protein bound to 
Glutathione SepharoseTM 4B resin was incubated with the prey protein and then extensively 
washed with buffer.  If there is interaction between the prey and the bait protein, it can be 
observed by the retention of prey protein on a gel containing the glutathione sepharose resin.  60 
μg of the GST-fusion protein was added to approximately 20 μL of sepharose beads (70 % 
solution) and incubated for 1 hour at 4°C and gently mixed on a Speci-Mix Aliquot Mixer 
(Barnstead International).  Beads were pelleted by centrifugation using a Microfuge® 18 
Centrifuge (Beckman CoulterTM) at 1476 x g for 1 min.  The supernatant was discarded and pellet 
was washed four times with 400 μL of 1X PBS pH 7.3.  As a next step, the purified protein was 
added and incubated for two hours at 4°C on a Speci-Mix Aliquot Mixer (Barnstead 
International).  Again the beads were washed with 1X PBS pH 7.3, after centrifugation at 1476 x 
g for 1min.  The supernatant was discarded and the remaining pellet was mixed with 15 μL of 
sample loading buffer boiled for 2 min and then analyzed by SDS-PAGE.  
2.6 Protein crystallization 
 When a homogenous protein solution reaches its limiting concentration, the protein no 
longer remains in the same state of solubility.  This phenomenon forms the basis of protein 
crystallization experiments (Asherie, 2004).  By changing the experimental conditions, the 
crystallographer tries to exceed the solubility limit of the protein so that it results in production 
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of crystals.  For the crystallization experiment, a phase diagram shows the state of protein as a 
function of various crystallization parameters (Chayen, 2004).  The phase diagram (Fig. 2.3) is 
used to quantify the effect of various parameters (protein concentration, precipitant concentration 
etc.) on the production of crystals.  Thus, phase diagrams give basic criteria to design the 
experiment for protein crystallization and optimization.  A typical crystallization phase diagram, 
consists of four zones representing different degrees of supersaturation.  The precipitation zone- 
an area of high supersaturation; moderate supersaturation zone - spontaneous nucleation takes 
place, the metastable zone - crystals are stable and may grow; and a zone of under-saturation - 
the protein is completely dissolved and chances of crystallization are less.  
 
Figure 2.3. Phase diagram for crystallization.   
Phase diagram showing various stages of crystallization experiment.  An area of high 
supersaturation where protein precipitates; an area of moderate supersaturation in which 
nucleation of protein is observed; a metastable zone where crystals can be observed and growth 
of crystals can be achieved due to lower supersaturation; an area of under saturation where protein 




2.6.1 Hanging drop vapor diffusion method  
Protein crystallization experiments were performed using a hanging drop vapor diffusion 
technique (Chayen, 1998).  The vapor diffusion technique is a commonly used method for 
crystallization.  It is based on the presence of precipitant which absorbs water from the 
crystallization drop hence driving the solution into supersaturated state and favoring 
crystallization. 8-10 mg/mL of the protein was used for setting up the crystallization drops in 
Linbro plates (Hampton Research).  The screens were set up using the Gryphon Robot (Art 
Robins Instruments).  The individual hanging drops were equilibrated against 1 mL of reservoir 
solution.  Each drop consists of 1 μL of the purified protein solution mixed with 1 μL of the 
reservoir solution.  
For optimization of crystallization conditions various parameters like initial protein 
concentration, incubation temperature, the effective pH of the reservoir/protein droplet, type of 
precipitant, additives such as salts, and the type of buffer were used to get favorable conditions 
for crystal growth.  
2.6.2 Seeding   
Seeding is a powerful technique used for the separation of nucleation and growth of 
crystals.  In this method, already grown crystals are used as seeds and introduced into new drops.  
These drops are equilibrated at lower levels of supersaturation prior to seeding.  Seeding in 
conjunction with other parameters such as the precipitant and protein concentrations, pH and 
additives can be optimized to get better quality crystals (Bergfors, 2003).  
2.7 Protein structure determination by Molecular Replacement and model building. 
For X-ray diffraction and data collection, the protein crystals were taken to Canadian 
Light Source (U of S, Saskatoon).  The data was collected at CMCF 08ID-1 beamline or at CMCF 
08Ba-1 BM beamline.  The diffraction data was processed with HKL2000 (Otwinowski and 
Minor, 1997).  For solving the structure of full length FliS, the PHASER molecular replacement 
method was used (McCoy et al., 2007).  Molecular Replacement is the method used to derive the 
phase information and solve a phase problem using the previously determined model of the 
structure.  Molecular Replacement (MR) provides an initial starting model for refinement.  In the 
absence of phases (Φ), it is difficult to complete the Fourier transform relating the experimental 
data in reciprocal space to real-space electron density, which in turn is used to build the atomic 
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model.  MR tries to find the model which best fits experimental intensities among already known 
structures.  The model was built using COOT (Emsley et al., 2010).  The first step of model 
building was to add backbone residues as well as side chains to the unoccupied areas of the 
electron density map and then the model was run thorugh the refinement program.  The R values 
(R-free and R-work) were used to monitor the progress of refinement process.  The process of 
model building and refinenment was repeated until the R values become stable and did not 



















3. Results  
3.1 Characterization of H. pylori FliH 
3.1.1 Cloning of H. pylori FliH (2-258) 
 For the cloning of the two new truncated variants of FliH it was necessary to clone the 
full length FliH (2-258) as a template.  For cloning of H. pylori FliH (2-258), H. pylori NCTC 
11637 genomic DNA was used as a template.  Standard cloning protocol was used as mentioned 
in materials and methods.  The full length FliH (2-258) comprised of 764 bp or 257 amino acids.  
After plasmid purification it was necessary to digest the plasmid using BamHI and EcoRI to 
check the size of gene of interest and vector.  Proper insertion of the gene of interest requires 
verification of correct orientation, absence of unwanted mutations, and ability to express the 
recombinant protein in-frame.  The desired gene fragment of interest was verified by plasmid 
digestion (Figure 3.1A) as well as by DNA sequencing (sequencing results not shown).  
Concentration of pGex-6P-3-FliH (2-258) plasmid after successful plasmid preparation was 
found to be 63.5 ng/µL.   
3.1.2 Cloning of two truncated FliH variants: FliH (57-258) & FliH (73-258)  
Previous characterization studies of full length H. pylori FliH in Dr. Moore’s lab did not 
yield any crystals.  Based on the sequence conservation of H. pylori FliH, previously FliH 89-
258 was cloned, purified and crystallized in Dr. Moore’s lab but due to poor diffraction quality 
of the crystals, the structure of the protein could not be determined.  Increasing the overall size 
of the construct may help in improving stability by means of affecting the subsequent secondary 
structure of the protein or by enhancing crystal lattice contacts between FliH molecules.  Hence 
longer constructs were designed which are listed as follows: FliH (57-258) & FliH (73-258).  The 
cloning was done for both the FliH constructs using the protocol mentioned in section 2.2.  The 
restriction digested plasmids were run on agarose gel (Figure 3.1B and 3.1C).  Based on the 
sequence (not shown) and size of DNA fragments on agarose gel it is confirmed that cloning of 
both the constructs was done successfully.  The plasmid concentration of pGex-6P-3-FliH (57-





Figure 3.1. Agarose Gel Electrophoresis of FliH (2-258), FliH (57-258) and FliH (73-258) 
plasmid digests.   
10 μL of plasmid was digested at 37°C O/N with the restriction enzymes BamHI and EcoRI (0.5 
μL @20,000 U/mL each), 5 μL of 10X Tango buffer (Fermentas).  8 μL of the sample was mixed 
with 2 μL of the 6X loading dye (Fermentas) and loaded on 1% agarose gel containing 3 μL of 
Hydragreen dye.  10 μL of 1 kb DNA ladder (Fermentas) was loaded to compare the size of the 
bands. The gel was run at 100V for 45-50 minutes.  The DNA was visualized under gel imager 
at 365 nm (Syngene Imager).  A. Sample 1 & 2 shows the digested FliH (2-258) at 764 bp and 
pGex-6P-3 plasmid at 4900bp.  B. The digested FliH (57-258) at 609 bp and pGex-6P-3 plasmid 











3.1.3 Optimization of protein expression FliH (57-258) & FliH (73-258)  
 Expression and purification of both the FliH fragments was done using E. coli BL21cells 
which provides an easy and fast system for overexpression of proteins.  The initial screening for 
maximum protein expression conditions was carried out using small-scale batch preps; harvested 
cells were lysed by sonication and separated into soluble and insoluble fractions by 
centrifugation.  The resulting supernatant was subjected to small-scale GST pull-down as 
mentioned in materials and methods section 2.5.3.  The GST pull-downs were analyzed by 15% 
SDS PAGE gels.  
 For determination of optimal conditions for expression of proteins different induction 
temperatures (25°C and 37°C) and different optical densities at 600 nm wavelength (OD600) (0.4, 
0.6, and 0.8) were used.  The small scale protein expression trials for proteins, FliH (57-258) & 
FliH (73-258) (Figure 3.2 and Figure 3.3 respectively) shows the difference in protein solubility 
at different temperature and ODs.  A significant proportion of the over-expressed protein was 
found to be soluble at 25°C and 0.8 OD, enabling further large-scale expression and purification 





Figure 3.2. Optimization of expression for FliH (57-258).   
FliH (57-258) was expressed in E. coli BL21 cells grown at 37°C or 25°C till desired OD600 and 
then protein expression was induced by adding 0.1 mM IPTG.  Different samples were incubated 
at different temperatures.  5 μL of protein samples were analyzed by 15% SDS-PAGE.  (A) 
Protein expression at 37°C at two different OD 0.4 and 0.6.  (B) Protein expression at 37°C at 0.8 
OD600 and 25°C at OD600 0.8.  (C) Protein expression at 25°C at OD600 0.4 and 0.6.  M- Marker, 










Figure 3 3. Optimization of expression for FliH (73-258).   
FliH (73-258) was expressed in E. coli BL21 cells grown at 37°C or 25°C till desired OD600 was 
reached and then protein expression was induced by adding 0.1 mM IPTG.  Different samples 
were incubated at different temperatures.  5 μL of protein samples were analyzed by 15% SDS-
PAGE.  (A) Protein expression at 37°C at two different OD 0.4 and 0.6.  (B) Protein expression 
at 37°C, 0.8 OD600 and at 25°C, OD600 0.8.  (C) Protein expression at 25°C OD600 0.4 and 0.6.  






3.1.4 Protein expression and GST affinity purification of FliH (57-258) & FliH (73-258) 
Following optimization of protein expression, large scale (4 L) expression of both the proteins, 
(FliH 57-258 and FliH 73-258) was carried out.  Purification was done by affinity 
chromatography as outlined in the section 2.5.2.  The same GS-affinity purification technique 
was used to purify all the proteins mentioned in this study.  The cells were lysed using a cell 
disruptor, and centrifuged at 20,400 x g using a JA-20 rotor for 60 min at 4°C to separate the 
soluble fraction from the insoluble fraction.  The lysate supernatant containing the soluble GST-
FliH (57-258) or GST-FliH (73-258) protein was purified by FPLC GS-affinity chromatography.  
The molecular weights of recombinant GST-FliH (57-258) and GST-FliH (73-258) were 
determined by ExPASy ProtParam tool (49 kDa and 44 kDa respectively).  The correct sized 
GST-fusion proteins were over-expressed and verified by SDS-PAGE, as the protein band 
migrated at its predicted molecular weight.  The chromatogram of the first GST affinity 
purification step verified the desired interaction of the GST tagged protein with the stationary 
phase (glutathione sepharose), which enabled purification from the unwanted whole cell extract.  
The FliH-GST fusion proteins were eluted from the glutathione sepharose column using reduced 
glutathione in elution buffer, this step is referred to as 1st GST in this study.  The GST tag was 
then cleaved by the addition of PreScission protease which allows removal of the GST-tag after 
second passage over the glutathione sepharose column, this step is referred to as 2nd GST.  Small 
samples of the proteins were removed after every step of purification for analysis by SDS-PAGE.   
Affinity purification of FliH (57-258)   
Figure 3.4 and Figure 3.5 shows the SDS gel images of FliH (57-258) fractions after each step of 
affinity purification.  The E. coli lysate supernatant was injected onto GS column.  The GST-FliH 
(57-258) fusion protein binds to the column and flow-through was washed away with 1X PBS.  
The bound fusion protein was then eluted using 50 mL elution buffer (50 mM Tris HCl pH 8.0, 
10 mM reduced glutathione).  Figure 3.4 shows the fractions analyzed by SDS PAGE.  The GST-
FliH (57-258) has a predicted molecular weight of approximately 49 kDa.  The predicted 
molecular weight FliH (57-258) from its sequence is approximately 23 kDa.  After dialysis of the 
eluted fusion protein in the cleavage buffer (pH 8.0) (50 mM Tris, 150 mM NaCl, 1 mM EDTA), 
80 units of PreScission Protease and 4 mM DTT was added.  The protein solution was kept at 
4°C for a minimum of 16 hours.  The GST cleaved FliH (57-258) was then subjected to a 2nd 
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round of GST purification wherein free GST binds to the Glutathione SepharoseTM 4B beads and 
pure protein comes out in flow through fractions (Figure 3.5).   
FliH (57-258) have predicted isoelectric point of 5.05, therefore it was decided to further purify 
it by anion exchange chromatography using a 10 mL Source-Q (SQ) column.  The column was 
equilibrated using 50 mL of buffer A (50 mM Tris-HCl pH 8.0, 25 mM NaCl).  Prior to injection, 
protein sample was subjected to dialysis in buffer A for about 16 hrs at 4 °C.  The protein was 
then injected on SQ column at a flow rate of 1 mL/min.  Figure 3.6 shows that FliH (57-258) 
binds to the column and it was eluted by applying a linear gradient of 25-500 mM NaCl over 
three column volumes using buffer A and elution buffer B (50 mM Tris-HCl pH 8.0, 2 M NaCl).  
Figure 3.6B shows that the protein was purified to homogeneity.   
 
Figure 3.4. Purification of FliH (57-258).   
Purity of the FliH (57-258) at various stages of purification was analyzed by 15% SDS-PAGE.  
5 μL of each sample was boiled with 5 μL of loading buffer and loaded on 15% SDS gel.  SDS-
PAGE was allowed run at a 115 V until the dye front reaches the bottom of the gel.  The gel was 
stained with Coomassie staining buffer for 30 min and then destained in destaining solution (7.5% 
v/v glacial acetic acid, and 10% v/v ethanol) for 4-5 hours.  Photographic image of the SDS-gel 
was taken using Gel Imager (Syngene Gel Imager).  M- Marker, Supernatant, E. coli lysate 
supernatant; 1st GST FT, flow-through fraction obtained after applying lysate supernatant onto 
the glutathione sepharose column;1st GST elutes (2-6), eluted fractions obtained after applying 




Figure 3.5. Purification of FliH (57-258).   
2nd GST flow-through fractions analysed by 15 % SDS-PAGE showing purity of the FliH (57-
258) after cleavage of GST tag.  FliH (57-258) migrates with the molcular weight of 23 kDa on 
15 % SDS gel.   
 
 
Figure 3.6. Purification of FliH (57-258) using Source-Q Anion Exchange Chromatography. 
A. Elution profile for purification of FliH (57-258).  The column was equilibrated in 50 mL of 
buffer A (50 mM Tris-HCl pH 8.0, 25 mM NaCl); the flow rate of injection was 1 mL/min.  The 
bed volume of the column was 10 mL.  Protein elution was monitored by absorbance (mAu) at 
280 nm.  B.  SDS-PAGE of FliH (57-258) anion exchange chromatography.  SQ elute peak 
fractions were analysed by 15 % SDS gel.  M-Protein marker; Lanes (1-8) - Elute peak fractions.  
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Following anion exchange chromatography, FliH (57-258) was concentrated as mentioned in 
section 2.4.9.  
Affinity purification of FliH (73-258)   
FliH (73-258) was purified in the same manner as FliH (57-258).  Figure 3.7 shows the SDS gel 
of the fractions after successive stages of purification. FliH (73-258) has molecular weight of 21 
kDa and predicted molecular weight of GST- FliH (73-258) fusion protein is approximately 47 
kDa.  The fusion protein remains bound to GS column which was then was then eluted using 50 
mL elution buffer (50 mM Tris HCl pH 8.0, 10 mM reduced glutathione).  Figure 3.7 shows the 
fractions analyzed by SDS PAGE.  The GST tag was cleaved similar to explained earlier in this 
study.  The sample was subjected to 2nd round of purification by injecting onto GS column.  The 
FliH (73-258) comes out as flow-through (Figure 3.7).   
 
Figure 3.7. Purification of FliH (73-258).   
Purity of FliH (73-258) at various stages of purification was analyzed by 15 % SDS-PAGE.  M- 
Marker; Supernatant - E. coli lysate supernatant; 1st GST FT - flow-through fraction obtained 
after applying lysate supernatant onto the glutathione sepharose column; 1st GST elutes- The 
eluted GST - FliH (73-258) (47 kDa) fractions obtained after applying lysate supernatant onto 
the glutathione sepharose column; Elutes+PSP+DTT - After dialysis of 1st GST elutes, 80 units 
of Prescision protease and 4 mM DTT was added to the protein sample for cleavage of GST tag; 





FliH (57-258) have predicted isoelectric point of 5.23.  Figure 3.8 shows the typical ion exchange 
elution profile for this protein.  All the fractions from the peak were analyzed by running a 15% 
SDS gel.  Figure 3.8 shows the fractions after ion exchange chromatography.  From the gel it can 
be stated that this protein was purified to homogeneity and can be used for crystallization.  All 
the fractions containing protein of interest were pooled and concentrated using 20 mM Bis-Tris 
propane pH 7.0, 100 mM NaCl, 2 mM TCEP.  Different concentrations of protein were analyzed 
by SDS PAGE (Figure 3.8).  The protein was concentrated as mentioned in methods section to 
10 mg/mL using an Amicon® Ultra-15 centrifugal filter device, 3 kDa Molecular Weight Cut 
Off (MWCO) and used for crystallization studies.   
 
 
Figure 3.8. Purification of FliH (73-258) using Source-Q Anion Exchange Chromatography.   
A.  Elution profile for purification of FliH (73-258).  The column was equilibrated in 50 mL of 
buffer A (50 mM Tris-HCl pH 8.0, 25 mM NaCl); the flow rate of injection was 1 mL/min.  The 
bed volume of the column was 10 mL.  Protein elution was monitored by absorbance (mAu) at 
280 nm.  B.  SDS-PAGE of FliH (73-258) anion exchange chromatography.  SQ elute peak 





3.1.5 In-vitro characterization of FliH (57-258) & FliH (73-258) by Size exclusion 
chromatography (SEC)   
 Gel filtration or size exclusion chromatography separates molecules/ proteins based on 
their molecular mass hence for determination of molecular mass of the protein, the SEC of the 
purified FliH (57-258) as well as FliH (73-258) were performed on SuperdexTM 200.  The column 
was equilibrated with 75 mL of 20 mM Tris pH 8.0 and 100 mM NaCl.  2 mg/mL of the protein 
was injected onto the column using a 500 μL injection loop.  The flow rate used for sample 
injection and elution was 0.5 mL/min. The protein was injected to the column.  Based on elution 
volume, molecular mass of the protein was calculated.   
FliH (57-258) eluted at 14.3 mL while FliH (73-258) eluted at 14.2 mL on Size excusion 
column.  The molecular weight of FliH (57-258) from its sequence is 23 kDa while the predicted 
molecular weight (based on standard calibration curve in Figure 3.10) was estimated to be 60 
kDa.  Hence it can be stated that this protein forms at least a dimer in solution.  Similarly, the 
molecular weight of FliH (73-258) from its sequence is 21kDa while the predicted molecular 
weight from SEC was estimated to be 60 kDa.  Therefore, based on the higher predicted molecular 
weight as well as broad peak size, it can be stated that the FliH most likely exists as an elongated 
dimer in solution.  Since Size exclusion chromatography gives approximate measurement of 
molecular weight, other sophisticated and sensitive methods like MALS (Multiangle Light 




Figure 3.9. Purification of FliH constructs using a Superdex 200 Size Exclusion column. 
The column was equilibrated with 20 mM Tris pH 8.0 and 100 mM NaCl.  2 mg/mL of the protein 
was injected onto the column.  The flow rate of 0.5 mL/min was used for injection as well as as 
elution.  A) A typical Superdex 200 elution profile for FliH(57-258).  FliH(57-258) eluted as a 
single peak with an elution volume of 14.3 mL (predicted molecular weight 60 kDa).  The eluted 
fractions were analysed by 15% PAGE gel.  B) A typical Superdex 200 elution profile for 
FliH(73-258).  FliH(73-258) eluted as a single peak with an elution volume of 14.2 mL (predicted 




Figure 3.10. Superdex 200 SEC calibration curve. 
The calibration curve for Superdex 200 SEC.   
Kav=Ve-V0/Vt-V0 
Where, V0 = void volume, Ve= elution volume and Vt= column volume; the void volume is the 
elution volume of Blue Dextran.  1=Ferritin, 2= Catalase, 3= Aldolase, 5= Ovalbumin, 6= 
Chymotrypsinogen.   
Table 3.1. Calibration data used for Superdex 200 SEC column.   
 Ve V0 Vt Kav MW logMW 
1. Ferritin 9.12 8.04 24 0.07 440,000 5.64 
2. Catalase  10.64 8.04 24 0.16 232,000 5.37 
3. Aldolase 12.40 8.04 24 0.27 158,000 5.2 
4. Albumin 14.00 8.04 24 0.37 67,000 4.83 
5. Ovalbumin 15.12 8.04 24 0.44 43,000 4.63 




3.1.6 Crystallization of FliH (57-258) & FliH (73-258) 
Crystallization of FliH (57-258)  
 Crystallization screening of the FliH 57-258 was performed at 20°C by the hanging-drop 
vapor-diffusion technique as discussed in Materials and Methods section 2.7.  For crystallization 
following screening kits were used: Wizard I and II (Rigaku reagents), Crystal Screen 1 and 
Crystal Screen 2 (Hampton Research), JCSG + suite (Qiagen), PACT suite (Qiagen).  The screens 
were set up using the Gryphon Robot (Art Robins Instruments) in 96 well crystal plates.   
 The drops with crystals were repeated manually using 24 well Linbro plates.  Each drop 
was prepared by mixing 1 μL of the protein solution (15.3 mg/mL) with 1 μL of the reservoir 
solution and was equilibrated against 1 mL of reservoir solution.  Many conditions showed 
likelihood of growing crystals (Figure 3.10).  Very small crystals were observed in drops 
containing 20% PEG 8000 + phosphate-citrate buffer pH 4.2+ NaCl.  We tried to optimize the 
conditions by varying the precipitant concentration, pH and additives in the original condition of 
2.0 M Ammonium sulfate + 0.1M Sodium citrate pH 5.5.  Depending on the results of all kits, 
some more grid screens were set up.  Within 4-5 days, small crystals were observed in drops 
containing 2.0 M Ammonium sulfate + 0.1M Sodium citrate pH 5.5 (Figure 3.11). 
 We collected the data of the very first crystal (from Ammonium sulfate + Sodium citrate 
condition) at the 081D-1 small gap undulator beamline, Canadian Light Source, University of 
Saskatchewan.  The crystal diffracted to approximately 3.9 Å.  The diffraction pattern of the 
crystals is shown in Figure 3.11.  Images were collected at a crystal to film distance of 290.0 mm.  
The exposure time per frame was 4 seconds.  Each frame was one-degree oscillation.  The 
wavelength was 0.97934 Å.  Even after extensive efforts it was impossible to reproduce the 





Figure 3.11. Crystallization of FliH(57-258).   
The crystallization of FliH(57-258) was performed by Hanging Drop Vapor Diffusion technique.  
The protein concentration used to set up plates was 15.3 mg/mL.  The plates were incubated at 
20°C in undisturbed condition.  Crystals obtained from drops prepared by mixing 1 μL of protein 
solution (15.3 mg/mL) and 1 μL of reservoir solution containing A) 2.0 M Ammonium sulfate + 
0.1M Sodium citrate pH 5.5, B) 20% P8K + 0.1 M CAPS pH 10.5 + 0.2M NaCl, C) 16% P8K + 




Figure 3.12. Diffraction images of the FliH (57-258) crystals.   
The diffraction images showing reflections up to 3.9 Å resolution limit.  The data was collected 

















Crystallization of FliH (73-258)  
 Initial crystallization screening for the FliH 73-258 was performed similar to FliH (57-
258).  Within 1 day small crystals were observed in drops containing 0.1 M Tris pH 8.0 + 20% 
PEG 6000 (Polyethylene Glycol).  This condition was optimized to get better quality crystals 
(Figure 3.13).  Each drop was prepared by mixing 1 μL of the protein solution (10 mg/mL) with 
1 μL of the reservoir.  We collected the data of these crystals at the 081D-1 small gap undulator 
beamline, Canadian Light Source, University of Saskatchewan.  The maximum diffraction 
obtained to 8 Å resolution limit.  The diffraction pattern of the crystals is shown is Figure 3.14.  
Images were collected at a crystal to film distance of 140.0 mm. The exposure time per frame 
was 10 seconds.  
 
Figure 3.13. Crystallization of FliH(73-258).   
The crystallization of FliH(57-258) was performed by Hanging Drop Vapor Diffusion technique.  
The protein concentration used to set up plates was 10 mg/mL.  The plates were incubated at 
20°C in undisturbed condition.  Crystals obtained from drops prepared by mixing 1 μL of protein 
solution and 1 μL of reservoir solution containing A) 0.1M Tris pH 8.0 + 20% P6K, B) 0.1M Tris 





Figure 3.14. Diffraction image of the crystal of FliH 73-258.   
The diffraction image for the crystals of FliH 73-258 showing reflections up to 8 Å resolution 
limit.  The crystals belong to monoclinic space group, with cell parameters a= 94 Å, b= 157.09 















3.2 Characterization of H. pylori FliI 
3.2.1 Cloning of FliI E193Q mutant  
The gene encoding FliI E193Q mutant was cloned in the pGEX-6P-3 vector.  Cloning of 
FliI E/Q mutant was done as described in Materials and Methods section 2.4.10.  FliI E193Q 
mutant gene is 1302 bp or 434 amino acids long.  The resultant image of agarose gel after 
successful cloning and plasmid digestion is shown in Figure 3.15.   
 
 
Figure 3.15. Plasmid digestion of the wild type and mutant FliI.   
Agarose Gel Electrophoresis of the digested wild type FliI Lane (1) and FliIE193Q lane (2) 
plasmids on 1% Agarose gel with 3μL of HydraGreen dye. 8μL of each the plasmid was mixed 
with 2 μL of 6X loading dye (Fermentas) and run the gel for 45-50 minutes @100V.  1kb DNA 
ladder was used as marker.  Lane 2 shows the digested FliI E193Q mutant at 1302 bp and pGEX-





3.2.2 Protein expression and purification of FliI E193Q mutant 
FliI E193Q mutant (47 kDa) was purified by affinity purification method as follows. 
 For expression purposes, E. coli BL21 cells were transformed with the FliI E193Q mutant 
plasmid, and the transformed cells were streaked for single colonies on LB Agar (Amp) plates. 
The agar plates were incubated at 37°C overnight.  A single colony was used to inoculate 50 ml 
of HyperbrothTM (Athena Enzyme SystemsTM), 2.5 mL Glucose Nutrient Mix (Athena Enzyme 
SystemsTM), 50 µL 100 ng/ µL of Amp and was incubated overnight at 37°C in a shaking 
incubator. The following day 2L of Amp Hyperbroth was inoculated with 20 mL of the overnight 
culture and grown at 37°C shaking incubator until 0.6 AU at OD600 nm.  For induction of protein 
expression 0.1 mM IPTG was added to the culture and then 2L of culture was incubated at 20°C 
overnight.  After incubation, the cells were harvested by centrifugation and lysed by cell 
disruptor, and separated into soluble and insoluble fractions by centrifugation. The pellet was 
then resuspended in lysis buffer and kept at -20°C for overnight.  Samples of the lysate, lysate 
supernatant and lysate pellet were kept for analysis and run on an SDS-PAGE gel (Figure 3.16).  
This gel shows that FliI expression has occurred but most of the protein is insoluble and resides 
in the lysate pellet.  The next day the lysate supernatant was subjected to 1st step of GS-affinity 
chromatography (1st GST) by loading the supernatant on GS-column (25 mL bed volume).  The 
bound GST-FliI fusion protein was easily removed using reduced glutathione in elution buffer.  
SDS gel image of the samples collected at each step of purification is shown in Figure 3.16. 
Following buffer exchange and treatment with PSP, the protein sample was again injected onto 
GS column (2nd GST) to remove free GST.  The FliIE193Q mutant protein flows through the 
column while GST remains bound to the column.  The bound GST is then removed from the 
column using elution buffer.  A small amount of sample was analyzed by SDS PAGE (Figure 
3.16)  
FliI E193Q has a predicted isoelectric point of 6.35, therefore it was decided to further 
purify this protein by anion exchange chromatography using a SQ column (10mL bed volume).  
The column was washed with 50 mL of buffer A (50 mM Tris pH 8.0, 1 M NaCl).  The cleaved 
FliIE193Q mutant protein was injected on SQ column at 1 mL/min flow rate and then flow rate 
was increased to 2 mL/min to wash out unbound protein for another 30 mL (Figure 3.17).  A 
linear gradient of 100-150 mM NaCl over 50 mL of elution buffer was applied to remove any 
 79 
 
bound protein.  50 mM Tris pH 8.0, 1 M NaCl was used as the elution buffer for anion exchange 
chromatography.   
Figure 3.17 shows the typical SQ profile for FliI E193Q mutant, which shows that this 
protein does not bind to the Source-Q sepharose, instead it passes through the column in the void 
volume.  The SDS-PAGE gel in Figure 3.17 indicates that anion exchange chromatography has 
resulted in purification of protein almost to homogeneity. But two major facts were observed 
during purification of FliI E/Q mutant.  First, the yield of this protein is very low and second, the 
FliI protein is not very soluble in solution, since precipitation was observed at every stage of 
purification.  The protein continues to precipitate until it reaches 2 mg/mL.  Precipitation of S. 
typhimurium FliI has also been observed (Dreyfus et al., 1993).   
 
Figure 3.16. Purification of FliI E193Q mutant.   
Purity of the FliI E193Q at various stages of purification was analyzed by 15% SDS-PAGE.  5 
μL of each sample was boiled with 5 μL of loading buffer and loaded on 15% SDS gel.  M - 
Marker, Pellet - lysate pellet, Supernatant - E. coli lysate supernatant, 1st GST FT - flow-through 
fraction obtained after applying lysate supernatant onto the glutathione sepharose column, 1st 
GST elutes - eluted fractions obtained after applying lysate supernatant onto the glutathione 
sepharose column, 1st GST elutes+ PSP+ DTT, 2nd GST FT (1-9) – Flow through fractions 
obtained from the 2nd GS purification step showing the presence of purified FliI E193Q mutant 




Figure 3.17.  Purification of FliI E193Q using Source-Q Anion Exchange Chromatography.  
A) Elution profile for purification of FliI E193Q.  The column was equilibrated in 50 mL of 
buffer A (50 mM Tris pH 8.0, 1 M NaCl); the flow rate of injection was 1 mL/min.  The bed 
volume of the column was 10 mL.  Protein elution was monitored by absorbance (mAu) at 280 
nm.  B) SDS-PAGE of FliI E193Q anion exchange chromatography.  Flow through and elute 
peak fractions were analyzed by 15 % SDS gel.  M-Protein marker; SQ FT- Ion exchange flow 










3.2.3 In-vitro characterization of H. pylori FliI E193Q mutant by Size exclusion 
chromatography  
SEC of the purified FliI mutant was performed on a SuperdexTM 200 column.  The column 
was equilibrated with 50 mM Na3PO4 pH 8.0, 150 mM NaCl and 5 mM MgCl2.  The purified 
protein was incubated in buffer containing 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM MgCl2, 
100 mM Urea, 10 mM AMP-PNP and 1 mM DTT for overnight at 4°C on a rocker.  The flow 
rate used for sample injection and elution was 0.5 mL/min.  Based on elution volume, molecular 
mass of the protein was calculated.  Salmonella FliI hexamerization has been observed in the 
presence of non-hydrolysable ATP analog by electron microscopy (Kazetani et al., 2009), hence 
it was decided to use AMP-PNP.  Based on gel filtration results for H. pylori FliI mutant (Figure 
3.18), it was predicted to be a monomer in solution.  
 
Figure 3.18. Purification of FliI E193Q mutant using a Superdex 200 Size Exclusion column.  
The column was equilibrated with 50 mM Sodium phosphate pH 8.0, 150 mM NaCl and 5 mM 
MgCl2.  2 mg/mL of the protein was injected onto the column.  The flow rate of 0.5 mL/min was 
used for injection as well as for elution.  A typical Superdex 200 elution profile for FliI E193Q 
mutant.  FliI E193Q mutant eluted as a single peak with an elution volume of 15.36 mL.  AMP-





The predicted molecular weight of FliI E/Q mutant from gel filtration chromatography 
(Standard curve in Figure 3.10) was found to be 48 kDa.  Despite conditions presumably 
favorable for hexamerization, FliI E193Q mutant did not form hexamers.  There could be three 
reasons for lack of hexamerization.  First, the experimental conditions are not sufficient enough 
for FliI mutant hexamerization.  FliI could be forming hexamer in very small concentration and 
size exclusion chromatography is not sensitive enough to detect the very small amount of 
hexamer.  Second reason could be that the protein is not folded properly.  The third possible 
reason is that FliI requires another protein/chaperone for its hexamerization.  Recently it has been 
observed that FliI requires another general chaperone called FliJ for its hexamerization.  FliJ 
promotes FliI hexamerization by binding at the center of FliI hexametric ring structure (Ibuki et 
al, 2013).  Further experimental evidence is required in order to confirm the oligomerization state 
of H. pylori FliI E193Q mutant.   
3.2.4 Crystallization trails for FliI (E/Q) mutant  
Crystallization trials for FliI E/Q mutant was carried out in presence of AMP-PNP in 
similar way as FliH crystallization, but no crystals were obtained for this protein. 
3.3 Making & characterization of FliH:FliI (E/Q) mutant complex  
We decided to check the interaction of FliH and FliI, since both the proteins could be 
over-expressed and purified.  Individual proteins FliH and FliI were purified by FPLC as 
mentioned earlier.  Both the proteins were mixed in a 1:1 molar ratio of the molecules.  The 
protein mixture was added to 5 mM MgCl2, 1 mM AMP-PNP and 2 mM DTT (final 
concentrations).  Final volume was made up to 500 uL using 1 x PBS.  The mixture was incubated 
for 30 min at room temperature on the rocker and injected on the Superdex 200 with the flow rate 
of 0.5 ml/min.  The Gel filtration profile of the FliH:FliI complex is shown in Figure 3.19A.  The 
fractions were collected and concentrated.  The samples were analyzed by loading on a15% SDS 
gel Figure 3.19B. 
Using the Superdex 200 calibration curve (Figure 3.10), the estimated molecular weight 
of peak 1 fractions was found to be 75 kDa.  Since molecular weight of monomeric FliI E/Q 
mutant is 47 kDa and that of FliH 57-258 is 21 kDa, there is a possibility of the formation of 
FliH2:FliI complex.  The solubility issues of the FliI mutant made the FliH:FliI complex difficult 
to concentrate and purify.  The protein solution was precipitating while concentrating possibly 
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due to poor solubility of the FliI.  It is difficult to determine the exact molecular weight of the 
complex using SEC, hence more sensitive techniques like MALS will be used in the future.   
 
Figure 3.19. SEC profile of the FliH:FliI E/Q mutant complex. 
A. Superdex 200 elution profile of mixture of FliH 57-258 and FliI E/Q mutant complex. Both 
the proteins were at concentration of 2 mg/mL before they were mixed.  The mixture contained 
500 μg of FliH 57-258 and 370 μg of FliI E/Q mutant, such that the proteins were at 1:1 molar 
ratio.  The protein mixture was incubated with 5 mM MgCl2, 1 mM AMP-PNP and 2 mM DTT 
at room temperature on rocker for 30 min, followed by injection onto Superdex 200 column.  B. 
15% SDS-PAGE of the fractions from 1st eluted peak.  Eluted fraction size- 2 mL/tube.  5 μL of 
each fraction was mixed with 5 μL of loading buffer and the sample was loaded on the gel 









3.4 Characterization of H. pylori HP0256  
3.4.1 Cloning of HP0256  
The gene encoding HP0256 was cloned in the pGEX-6P-3 vector.  Cloning of HP0256 was done 
as described in Materials and Methods section 2.2.  HP0256 gene is 441 bp or 147 amino acids 
long.  The restriction digested plasmid was run on agarose gel (Figure 3.20). 
3.4.2 Protein expression and purification of HP0256 
Purification of HP0256 (16 kDa) was carried out by Affinity Chromatography using the 
same protocol as for other proteins.  The SDS gel image of the purified protein is shown in figure 
3.21.  The purified protein was concentrated to 10 mg/mL and used for SEC by Superdex 200 
column.  The column was equilibrated with 20 mM Tris pH 8.0 and 100 mM NaCl.  The flow 
rate used for sample injection and elution was 0.5 mL/min.  Based on elution volume (30.8 mL), 
the predicted molecular mass of the protein was calculated (Figure 3.22).  The molecular weight 
of FliJ from its sequence is 16 kDa while the molecular weight of this protein from gel filtration 
was estimated to be 24 kDa hence it can be presumed that FliJ remains as a monomer in solution. 
Figure 3.20. Plasmid digestion of the HP0256 gene.   
Agarose Gel Electrohporesis of the HP0256 plasmids (digested with BamHI and EcoRI, 2 μL 
@20,000 U/mL each) on 1% Agarose gel with 3μL of HydraGreen dye. 8μL of each plasmid was 
mixed with 2 μL of 6X loading dye (Fermentas) and run the gel for 45-50 minutes @100V.  1kb 
DNA ladder was used as marker.  Lanes 1-3 shows the digested HP0256 at 441 bp and pGex-6P-




Figure 3.21. Purification of HP0256 using Source-Q Anion Exchange Chromatography.  
Purity of HP0256 at various stages of purification was analyzed by 15 % SDS-PAGE.  M- 
Marker; U – uninduced sample; P – E. coli lysate pellete; S - E. coli lysate supernatant; GST - 
The eluted GST-HP0256 fusion protein (42 kDa) fractions obtained after applying lysate 
supernatant onto the glutathione sepharose column; 2nd GST FT - flow-through fractions from 
the 2nd GST purification HP0256 (16 kDa); SQ – Elutes obtained after applying cleaved HP0256 
to the ion-exchange column.   
 
Figure 3.22. Purification of HP0256 using a Superdex 200 Size Exclusion column.   
The cloumn was equilibrated with 20 mM Tris pH 8.0 and 100 mM NaCl.  2 mg/mL of the protein 
was injected onto the column.  The flow rate of 0.5 mL/min was used for injection as well as for 
elution.  A typical Superdex 200 elution profile for HP0256 is shown.  HP0256 eluted as a single 
peak with an elution volume of 30.8 mL (predicted molecular weight 24 kDa).   
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3.4.3 Crystallization trials for HP0256 
The initial screen for crystallization was carried out using a Gryphon robot.  Crystallization 
screening of the HP0256 was performed at 20°C by the hanging-drop vapor-diffusion technique 
by using the following screening kits: Wizard I and II (Rigaku reagents), Crystal Screen 1 and 
Crystal Screen 2 (Hampton Research), JCSG + suite (Qiagen), PACT suite (Qiagen).  Within 1 
day small crystalline precipitates were observed in a few drops (Figure 3.23).  Optimization of 
crystallization is currently in progress. 
Figure 3.23. Crystallization of HP0256.   
The crystallization of HP0256 was performed by Hanging Drop Vapor Diffusion technique.  The 
protein concentration used to set up plates was 8.5 mg/mL.  The plates were incubated at 20°C.  
Crystalline precipitates/phase seperation obtained from drops prepared by mixing 1 μL of protein 
solution and 1 μL of reservoir solution containing A) 10% w/v PEG 8000 + 0.1 M Tris pH 7.0 + 
0.2 M MgCl2, B) 0.1 M MES pH 6.0 + 0.2 M Zn(OAc)2 + 12% Isopropanol, C) 10% w/v PEG 
8000 + 0.1 M CHES pH 9.5 + 0.2 M NaCl, D) 30% v/v PEG 400 + 0.1 M  CAPS pH 10.5  
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3.5 Characterization of FliS and FlaA2 (463-488) 
3.5.1 Cloning of FliS, FlaA2 (463-488) 
Cloning of FliS (378bp), FlaA2 (463-488) (138bp) was done from H. pylori NCTC 11637genomic 
DNA using standard cloning protocol.  After successful cloning the concentration of plasmids 
were found to be 188.5 ng/µL and 147.5 ng/µL respectively.  The resultant image of agarose gel 
after successful cloning and plasmid digestion is shown in Figure 3.24. 
Figure 3.24. Plasmid digestion of the FliS, FlaA2 (463-488) gene.   
Agarose Gel Electrohporesis of the FliS, FlaA2 (463-488) (digested with BamHI and EcoRI, 2 
μL @20,000 U/mL each) plasmids on 1% Agarose gel with 3μL of HydraGreen dye. 8μL of each 
plasmid was mixed with 2 μL of 6X loading dye (Fermentas) and run the gel for 45-50 minutes 
@100V.  1kb DNA ladder (L) was used as marker.  A) Lanes 1&2 shows the digested FliS at 378 
bp and pGex-6P-3 plasmid at 4900 bp, B) Lane 1 shows the digested FlaA2 (463-488) at 138bp 
and pGex-6P-3 plasmid at 4900 bp.   
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3.5.2 Expression and purification of FliS  
FliS was purified using the same method as described in Materials and Methods section 2.4.  
Figure 3.25 shows the SDS gel of the fractions after successive stages of purification. FliS has 
molecular weight of 14.5 kDa (126 amino acids) and predicted molecular weight of GST- FliS 
fusion protein is approximately 40.4 kDa.  The fusion protein remains bound to GS column which 
was then was then eluted using 50 mL elution buffer (50 mM Tris HCl pH 8.0, 10 mM reduced 
glutathione).  Figure 3.25 shows the fractions analyzed by SDS PAGE.  The GST tag was cleaved 
in similar way as explained earlier in this study.  The sample was subjected to 2nd round of 
purification by injecting onto GS column.  The FliS comes out as flow-through. 
  
Figure 3.25. Purification of FliS by GS-Affinity purification method.   
Purity of the FliS at various stages of purification was analyzed by 15% SDS-PAGE.  5 μL of 
each sample was boiled with 5 μL of loading buffer and loaded on 15% SDS gel.  M - Marker, 
Pellet - lysate pellet, Supernatant - E. coli lysate supernatant, 1st GST FT - flow-through fraction 
obtained after applying lysate supernatant onto the GS column, 1st GST elutes - eluted fractions 
obtained after applying lysate supernatant onto the GS column, 2nd GST FT – Flow through 
fractions obtained from the 2nd GS purification step showing the presence of purified FliS protein 
at 14.5 kDa, 2nd GST elutes- eluted GST fractions at 26 kDa, SQ elutes (1-4) - Eluted FliS 




FliS has predicted isoelectric point of 5.03, therefore it was decided to further purify this protein 
by anion exchange chromatography using SQ column.  The column was washed with 50 mL of 
buffer A (50 mM Tris pH 8.0, 1 M NaCl).  The cleaved FliS protein was injected on the SQ 
column at 1 mL/min flow rate and then the flow rate was increased to 2 mL/min to wash out 
unbound protein for another 30 mL.  The FliS was eluted by applying a linear gradient of 100-
150 mM NaCl over three column volumes using buffer A and elution buffer B (50 mM Tris-HCl 
pH 8.0, 2 M NaCl).  The eluted fractions were analyzed by SDS-PAGE gel (Figure not shown).   
Appropriate fractions containing FliS were pooled and concentrated to 10 mg/mL using an 
Amicon® Ultra-15 centrifugal filter device, 3 kDa Molecular Weight Cut Off (MWCO) and 
utilized for crystallization studies.  Purified FliS was analyzed by SDS-PAGE gel (Figure 3.26) 
 
Figure 3.26. Purification of FliS using Source-Q Anion Exchange Chromatography.   
A) Elution profile for purification of FliS.  The column was equilibrated in 50 mL of buffer A 
(50 mM Tris pH 8.0, 1 M NaCl); the flow rate of injection was 1 mL/min.  The bed volume of 
the column was 10 mL.  Protein elution was monitored by absorbance (mAu) at 280 nm.  B) The 
appropriate fractions were pooled and concentrated to 10 mg/mL and were analyzed by 15 % 
SDS-PAGE gel.   
 90 
 
3.5.3 In-vitro characterization of FliS by Size exclusion chromatography 
Gel filtration or size exclusion chromatography separates molecules/ proteins based on their 
molecular mass hence for determination of molecular mass of the protein, the SEC of the purified 
FliS was performed on SuperdexTM 75.  The column was washed with 75 mL of water and then 
equilibrated with 75 mL of Buffer A 10 mM Tris pH 8.0.  2 mg/mL of the protein was injected 
onto the column using a 500 μL injection loop.  The flow rate used for sample injection and 
elution was 0.5 mL/min.  The FliS eluted at 13.2 mL (Figure 3.27).  Based on the elution volume, 
molecular mass of the protein was calculated.  The molecular weight of FliS from its sequence is 
14.5 kDa while the predicted molecular weight from standard curve (Figure 3.28) was estimated 
to be 17 kDa.  The Salmonella FliS have been shown to form dimer in solution (Auvray et al., 
2001).  Yet, from the SEC results it can be stated that H. pylori FliS is present as a monomer in 
solution.   
 
Figure 3.27. Purification of FliS using a Superdex 75 Size Exclusion column.   
The cloumn was equilibrated with Buffer A 10 mM Tris pH 8.0, 150 mM NaCl.  2 mg/mL of the 
protein was injected onto the column.  The flow rate of 0.5 mL/min was used for injection as well 
as for elution.  A typical Superdex 75 elution profile for FliS.  FliS eluted as a single peak with 




Figure 3.28. Superdex 75 SEC calibration curve. 
The calibration curve for Superdex 75 SEC.   
Kav=Ve-V0/Vt-V0 
Where, V0 = void volume, Ve= elution volume and Vt= column volume; the void volume is the 
elution volume of Blue Dextran.  1= Albumin, 2= Ovalbumin, 3= Chymotrypsinogen A, 4= 
Ribonuclease, 5= Aprotinin, 6= Vitamin B12.   
Table 3.2. Data used for Calibration of Superdex 75 column 
 Ve V0 Vt Kav MW logMW 
1. Albumin 9.84 7.84 24 0.12 67000 4.826 
2. Ovalbumin 10.88 7.84 24 0.19 43000 4.633 
3. Chymotrypsinogen A 12.8 7.84 24 0.31 25000 4.397 
4. Ribonuclease 13.8 7.84 24 0.37 13700 4.136 
5. Aprotinin  15.73 7.84 24 0.49 6500 3.812 
6. Vitamin B12 19.15 7.84 24 0.70 1355 3.131 
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3.5.4 Crystallization of FliS 
The purified FliS was concentrated and various concentrations starting from 4 mg/mL to 
10 mg/mL were used for crystallization.  Plates with 4 mg/mL protein concentration shoed the 
presence of crystals hence it was decided to carry out crystallization for FliS at 4 mg/mL.  The 
initial screen for crystallization was carried out using a Gryphon robot.  Crystallization screening 
of the FliS was performed at 20°C by the hanging-drop vapor-diffusion technique by using the 
following screening kits: Wizard I and II (Rigaku reagents), Crystal Screen 1 and Crystal Screen 
2 (Hampton Research), JCSG + suite (Qiagen), PACT suite (Qiagen).  Within 1 day small 
showers of crystals were obtained in drop containing 10% v/v Iso-Propanol + 0.1 M MES pH 6.0 
+ 0.2 M Ca(OAc)2 (Figure 3.29A) and 0.1 M HEPES-Na pH 7.5 + 10% v/v Iso-Propanol + 20% 
PEG 4000.  For getting good crystal packing, slow and steady growth of the crystal is very 
important.  We collected the dataset for a few crystals at Canadian light source, U of S.  Some of 
the data sets were not useful for solving crystals due to poor quality.  One of the crystals showed 
good diffraction up to 2Å resolution but we could not process the diffraction images using HKL 
2000 software (Otwinowski and Minor, 1997).  In the case of FliS, crystals were growing very 
fast therefore we decided to use Al’s Oil (Hampton research), MPD (2-methyl-2, 4-pentanediol), 
PEG 400, Glycerol to optimize the crystal growth.  Various parameters like protein concentration, 
pH of the buffer, salt concentration etc. were used to optimize the crystal growth.  Al’s Oil and 
4% MPD as well as HXD (1, 6-Hexanediol) (Sigma-Aldrich) helped to slow down the growth of 
crystals.  Incubation at lower temperature (15°C) helped to get good crystals.  Finally, good 
quality crystals were obtained with drops containing 0.1 M MES + 0.2 M Ca(OAc)2 + 7% (v/v) 
2-propanol + 4% MPD using 4.5 mg/mL protein concentration.  The drops were prepared by 
mixing 3 µL of protein solution with the 3 µL of reservoir solution.  The reservoir solution was 
covered with 400 µL Al’s oil.  Within 4-5 days small crystals appeared and they grew slowly 
within next couple of days.  Crystals from several promising conditions were subjected to 
diffraction.  The diffraction experiments were carried out at the Canadian Light Source (CLS) at 





Figure 3.29. Crystallization of FliS.   
The crystallization of FliS was performed by Hanging Drop Vapor Diffusion technique.  The 
plates were incubated at 15°C.  Crystals obtained from drops prepared by mixing 3 μL of protein 
solution and 3 μL of reservoir solution.  A) Protein concentration - 3.8 mg/mL; incubation 
temperature 20°C reservoir-10% (v/v) 2-propanol + 0.1 M MES pH 6.0 + 0.2 M Ca(OAc)2, B) 
Protein concentration – 5.8 mg/mL; reservoir - 6% (v/v) 2-propanol + 0.1 M MES pH 6.5 + 0.2 
M Ca(OAc)2 + 4% MPD, C) Protein concentration – 4.5 mg/mL; reservoir - 7% (v/v) 2-propanol 
+ 0.1 M MES pH 6.3 + 0.2 M Ca(OAc)2 + 5% MPD; D) Protein concentration – 4.5 mg/mL; 






3.5.5 Crystal structure of FliS 
 The diffraction data was processed by Michel Fodje using XDS software (Kabsch, 2010).  
For refinement and structure solving, Phaser crystallographic software was used (McCoy et al., 
2007).  The structure of FliS (101 residues) has been refined. The data showed reflections up to 
2.2 Å resolution, but for solving structure we used reflections only upto 2.45 Å resolution.  The 
structure contains two molecules in the asymmetric unit.  The crystal was found to have a space 
group of P 21 21 21 with unit cell parameters a=33.86, b=82.63, c=92.26 and α=β=γ=90°.  The H. 
pylori FliS (PDB ID 3IQC) was used as a search model for solving the structure by molecular 
replacement.  Initially a poly-alanine model was used for residues whose density map was not 
observed.  All the residues whose side chain density was not observed, were replaced by an 
Alanine residue and then the model was refined to see if the density comes back.  The residues 
with missing backbone density were omitted from final structure.  The process was repeated until 
Rfree and Rwork values considerably decreased (0.46 and 0.40).  For proteins R-factor ranges 
between 0.6 (for imperfectly refined model) to 0.2 (for well refined model).  The final model is 
shown in Figure 3.32.   
Phenix.Xtriage was used to check the quality of the data.  It calculates various statistical 
parameters (like solvent content and Matthews coefficient, twinning and NSC, data strength and 
completeness etc.) to indicate the quality of the data.  In this case the presence of twinning (Figure 
3.31) or weak translational pseudosymmetry (from Patterson analysis) can be responsible for 
slightly high R-value.  The data also showed the presence of anisotropy.  We could not improve 





Figure 3.30. The X-ray diffraction pattern of a FliS crystal.   
A. The diffraction image showing reflections up to 2.2Å resolution limit. B. Zoomed image of 
the diffraction pattern.  The data was collected at 081D-1 small gap undulator beamline.   
Figure 3.31. NZ test to detect twinning or possible translational NCS. 
The plot of Z-score vs P-value (the probability equal to 9.982e-01) to detect the presence of 
twinning or possible translational non-crystallographic symmetry (NCS).  The sigmoidal curve 
of the plot indicates the presence of twinning or possible NCS. 
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The structure of H. pylori FliS showed the presence of antiparallel four-helix bundle (Figure 
3.32).  The residues 3-20 of N-terminal region were disordered hence they were removed from 
the final structure.  The C-terminal 5 residues were also removed.  The final structure contained 
residues 21-121.  The N-terminal conserved residues (for example Tyr 10, Tyr 28) plays a very 
important role in flagellin binding (Figure 3.32).  It has been observed in A. aeolicus that two out 
of the four protomers from the asymmetric unit in the FliS crystal have their N-termini disordered 
while other two molecules showed the presence of a quasi-helical cap formed by the 15 N-
terminal residues (Evdokimov et al., 2003).   
 
Figure 3.32. The structure of H. pylori FliS (21-121).   
Two orientations of the H. pylori FliS structure, related by 180° rotations are drawn using PyMOL 
software.  An antiparallel four-helix bundle is shown in cyan color and the linker segments are in 





Figure 3.33. The structure of N-terminal conserved residues in FliS.   
The core helix bundle of FliS in shown is yellow.  The highly conserved residues which are 
important in FliS-flagellin interaction are shown in green.  The moderately conserved residues 
are not shown in this structure.  The N-terminal 19 residues were removed from the final structure.  
Tyr 10 which is one of the highly conserved residues, is not shown.  The structure was generated 















Table 3.3. Data collection and refinement statistics  
Resolution range (Å) 46.13-2.45 (2.74-2.45) 
Space group P 21 21 21 
Unit cell a=33.86, b=82.63, c=92.26  
α=β=γ=90  
Observed reflections  70258 
Unique reflections 10092 (2777) 
Redundancy 6.96 (7.15) 
Completeness (%) 99.97 (100) 
Wilson B-factor 28.34 




Details of refinement  
R-work 0.4028 (0.3728) 
R-free 0.4693 (0.4233) 




Ramachandran favored (%) 91.3 
Ramachandran outliers (%) 2.9 
Average B-factor  32.30 
(Values in parentheses are for the highest resolution shell.) 
*Rmerge= ΣhklΣi|Ii(hkl) - <I(hkl)>|/ ΣhklΣi Ii(hkl) 
Footnote- The data showed reflections upto 2.1 Å but for data processing we used reflections only upto 
2.45 Å since beyond 2.45 Å, the data was not complete.  
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3.5.6 FliS: FlaA complex  
 Crystal structure of FliS in complex with flagellin from A. aeolicus was already 
determined (Evdokimov et al., 2003).  The FliS from A. aeolicus shows 31% sequence identity 
with H. pylori FliS (sequence data not shown).  It has been observed that Salmonella FliS interacts 
with the C-terminus of FliC (Auvray et al., 2001; Ozin et al., 2003), hence we decided to check 
this interaction in H. pylori.  GST-pulldown method was used to check the interaction between 
FliS and N-terminus of flagellin.  Both the proteins were mixed in approximately 1:2 molar ratios.  
100 µL of 70% GS beads were incubated with GST-FlaA2 (200 µg of GST-FlaA2) at room 
temperature for 10 mins.  The sample was then washed with 400 µL of buffer B (10 mM Tris pH 
7.5, 150 mM NaCl, 2 mM DTT and 0.5 mM EDTA).  The washing step was repeated 3 more 
times.  25 µL of the sample was mixed with 200 µg of FliS and incubated for another 20 minutes 
at room temperature.  The incubated protein mixture was again washed 4 times with buffer B to 
remove unbound protein.  5 µL of the sample was mixed with 5 µL of loading buffer and run on 
SDS-PAGE gel.  Figure 3.33 shows that GST-FlaA binds to H. pylori FliS.   
 
Figure 3.34. FliS-FlaA complex pulldown.   
100 µL of 70% GS beads were incubated with GST-FlaA2 (200 µg of GST-FlaA2) at room 
temperature for 10 mins.  The sample was then washed with 400 µL of buffer B (10 mM Tris pH 
7.5, 150 mM NaCl, 2 mM DTT and 0.5 mM EDTA).  The washing step was repeated 3 more 
times.  25 µL of the sample was mixed with 200 µg of FliS and incubated for another 20 minutes 
at room temperature.  The washing step was repeated four times to remove unbound protein.  5 
µL of the sample was mixed with 5 µL of loading buffer and run on 15% SDS-PAGE gel.   
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4. Discussion  
4.1 Protein purification and crystallization of FliH, FliI and HP0256  
 This project started with the in-vitro characterization of two constructs of FliH (FliH 57-
258 and FliH 73-258).  When this study began, there was no structure available for Salmonella 
FliH/ H. pylori FliH.  The genes for both the proteins were cloned successfully and the protein 
purification was done using GS-affinity chromatography.  These proteins were subjected to 
calibrated SEC to determine the approximate molecular masses.  The molecular weight of FliH 
(57-258) from its sequence is 23 kDa while the predicted molecular weight from SEC was 
estimated to be 60kDa.  Similarly, the molecular weight of FliH (73-258) from its sequence is 21 
kDa while the predicted molecular weight from SEC was estimated to be 60 kDa.  The SEC 
results (the higher predicted molecular weight as well as broad peak size) suggests that both the 
FliH proteins form an elongated dimer in solution.  The study in Salmonella has confirmed that 
FliH forms a stable dimer in solution (Minamino and Macnab, 2000).  Further experiments are 
necessary to confirm the oligomerization state of this protein.   
 The crystallization experiments of FliH were performed successfully.  For FliH (57-258), 
the major issue was the reproducibility of the crystals.  Even after extensive optimization, it was 
difficult to reproduce crystals.  For FliH (73-258), crystal reproducibility was not an issue but the 
diffraction quality of the crystals was poor.  The crystals of FliH (73-258) showed weak 
diffraction pattern and highly anisotropic hence we were not able to determine the structure of 
FliH.  Although low/moderate anisotropy can be tackled by some data reduction software like 
HKL-2000 but processing of highly anisotropic data becomes challenging (Wlodawer et al., 
2014).  Further crystallization studies are required for both these proteins.  Reductive methylation 
of proteins has been shown to improve the quality of the crystals in some cases (Walter et al., 
2006), therefore it can be used as one of the strategies to improve quality of these crystals in 
future experiments.  Slightly longer constructs of FliH may be used in future experiments to check 
crystallization.  Another approach to improve crystallization is by leaving the tag on the proteins 
(His-tag).  It has been observed for many proteins that a small tag like His-tag helps in 
crystallization of protein.   
 Previously in Dr. Moore’s lab, full length FliI as well as an N-terminal constructs of FliI 
have been cloned, purified and characterized.  Due to poor solubility of the FliI, limited studies 
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were carried out on structural characterization of this protein.  It is known about the role of 
glutamate 193 in ATP hydrolysis, hence we decided to clone the FliIE193Q mutant.  The carboxyl 
group of glutamate 193 polarizes a water molecule for the nucleophilic attack to the γ-phosphate 
of ATP (a general base catalysis).  Therefore, the replacement of Glutamate by Glutamine should 
result in the complete loss of ATPase activity (Shimabukuro et al., 2003; Kazetani et al., 2009).  
The idea behind the expression of H. pylori FliI E/Q mutant in the presence of AMP-PNP (a non-
hydrolysable analog of ATP) was to reveal whether this substrate binds to the active site of the 
FliI which might create a conformational change thus regaining ATPase activity allosterically.  
In presence of AMP-PNP, the yield of complete hexameric FliI rings increases by 20-fold, 
presumably by stabilizing the assembled oligomers (Claret et al., 2003).   
 FliIE193Q mutant was cloned and purified successfully.  The yield of FliIE193Q mutant 
protein was low similar to wild type FliI.  The FliIE193Q mutant precipitated at every stage of 
purification and continued till it reaches to the concentration of 2 mg/mL.  From the gel filtration 
results for H. pylori FliIE193Q mutant, it was predicted to be a monomer in solution.  The 
theoretical molecular mass of FliIE193Q mutant from its sequence was 47 kDa.  The predicted 
molecular mass of FliI E/Q mutant from gel filtration chromatography was found to be 65 kDa.  
Despite conditions presumably favorable for hexamerization (50 mM Tris-HCl pH 8.0, 100 mM 
NaCl, 5 mM MgCl2, 100 mM Urea, 10 mM AMP-PNP and 1 mM DTT), FliI E193Q mutant did 
not form hexamers.  This can be because of the experimental conditions.  Claret and colleagues 
have observed FliI ring formation by electron microscopy (Claret et al., 2003).  Furthermore, 
they have observed by gel filtration chromatography that the FliI forms higher order 
oligomers/hexamers in the presence of ATP however 60% of the total protein remains as a 
monomer.  Hence it is possible that in this project, even if FliI is forming hexamer in very low 
concentration, it is impossible to detect by gel filtration.  Electron microscopy can be used to 
observe hexamerization of FliI.  Another possible reason for absence of hexamers could be that 
the protein is not folded properly.  The partial misfolded protein may not be able to form 
hexamers.  Another possible reason for absence of FliI hexamer could be that FliI needs another 
protein/chaperone to form hexamer.  Recently it has been observed that FliJ promotes FliI 
hexamerization by binding at the center of FliI hexameric ring structure (Ibuki et al, 2013).  Hence 
further experimental evidence is required to confirm the oligomerization state of FliI in H. pylori.  
The crystallization experiments of the FliIE193Q mutant protein did not produce any crystals.  
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This can be due to precipitation issues observed during purification or probable misfolding of 
FliI.   
  FliJ plays a very important role in the flagellar export system as lack of FliJ results in 
leaky motile phenotype in Salmonella (Minamino et al., 2000).  FliJ binds and promotes cycling 
of the export chaperones FlgN and FliT (Douillard et al., 2010).  It interacts with FliH, FliI as 
well as with export gate component FlhA (Minamino & Macnab, 2000).  It is a general component 
of flagellar export apparatus and has chaperone-like activity.  Recent bioinformatics studies have 
identified HP0256 from H. pylori as a potential FliJ homologue (Douillard et al., 2010).  FliJ 
promotes FliI hexamerization by binding at the center of FliI hexameric ring structure (Ibuki et 
al, 2013).  Since FliJ acts as the adapter that links the substrate-chaperone complexes to export 
gate, the structural details of HP0256 will reveal the insights of the export process.  The 
restoration of motility has been observed after complementing the gene in HP0256 knock out 
mutant lacking motility (Douillard et al., 2010).  To prove that HP0256 is a FliJ homolog we 
decided to characterize HP0256.  After successful cloning and protein purification of HP0256, 
SEC was carried out.  The molecular weight of HP0256 from its sequence is 16 kDa while the 
estimated molecular mass from SEC was 24 kDa hence it can be presumed that FliJ remains as a 
monomer in solution.  Unfortunately, no crystals were observed for HP0256 using standard 
crystallization conditions (commercially available crystallization kits - approximately over 500 
conditions).  Other approaches like Y2H genetic analysis, gene complementation studies cn be 
used to confirm that HP0256 is a FliJ homolog.   
 In summary, we were successful in cloning and purification of FliI, HP0256 and 
crystallization of FliH constructs.   
4.2 FliH:FliI E193Q binding studies  
 The SEC was used to study the interaction between FliH and FliIE193Q mutant.  Based 
on SEC results the estimated molecular mass of the FliH:FliIE193Q complex was found to be 75 
kDa.  Molecular weights of the individual proteins (FliH and FliIE193Q) were 21kDa and 47kDa 
respectively.  Hence there is possibility of FliH2:FliI complex but just based on SEC results it is 
difficult to determine the exact stoichiometry of the complex.  Further experiments are required 
to confirm the exact molar ratio of the FliH and FliI in the complex.   
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4.3 Crystallization and the structure of FliS  
 Purification and crystallization of FliS was carried out successfully.  The FliS crystals 
diffracted to 2.1 Å resolution but the data was incomplete beyond 2.45 Å resolution therefore for 
solving the structure of FliS we used data upto 2.45 Å resolution.  The structure is not fully refined 
due to the data quality.  The data quality also suggested that there is possibility of twinned crystal 
therefore to get good data, we might attempt to re-crystallize this protein in future.  The structure 
of FliS showed an antiparallel four-helix bundle.  The N-terminal residues were disordered in the 
structure hence were removed from the final structure.  Apart from Tyr10, all other highly 
conserved residues were present in the final structure.  The N-terminal conserved residues form 
a hydrophobic pocket for the binding of a flagellin molecule.   
 The GST-pulldown results confirm that, FliS interacts with the flagellin protein in H. 
pylori.   
5. Future directions  
 Crystal screens of FliH so far have not yielded any structure.  Thus for structural studies 
of H. pylori FliH, slightly longer constructs might give good diffraction data.  Also, reductive 
methylation of lysine residues can be a good strategy to improve crystal quality.  Crystallization 
of FliIE193Q mutant and HP0256 require further experiments.  We have shown in this thesis that 
FliH and FliIE193Q forms a complex, sophisticated techniques like MALS will be useful to 
confirm the oligomerization state of the complex.  The structure of FliS-flagellin complex will 
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